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 ABSTRACT 
Colostrum is vital to the newborn pig. Hence, cross-fostering is employed to equalize the 
number of piglet between litters ensuring colostrum intake for their survival and growth. 
However, little is known about the impact of cross-fostering on the intestinal microbiome and 
mucosal immune gene expression of the neonatal pig. Twenty-four piglets were enrolled in the 
study to determine the influence of maternal microbial communities and to establish a baseline 
for mucosal immune gene expression in young pigs reared in cross-fostering model given high 
quality colostrum from birth dam or foster dam upon birth. Piglets were randomly assigned to 1 
of 3 treatments according to colostrum source and postcolostral milk feeding for 21 days, as 
follow: treatment 1 (n = 8), received colostrum and post-colostral milk feeding from their own 
dam; treatment 2 (n = 8), received colostrum from foster dam and returned to their own dam for 
post-colostral milk feeding; and treatment 3 (n = 8), received colostrum and post-colostral milk 
feeding from foster dam. DNA was extracted from nasal, fecal, and gastrointestinal (GI) tract of 
the piglets and from colostrum, vaginal, and fecal samples of the sows. Tissues from intestinal 
mucosa in jejunum, ileum, colon, peyer’s patches, and associated lymph nodes were utilized. 
Quantitative real-time PCR analysis was performed to quantify the expression of toll-like 
receptors (TLR) 2, 4, and 10, tumor necrosis factor alpha (TNFα), interferon gamma (IFNγ), and 
interleukin (IL) 4 and 10. Discriminant analysis revealed that bacterial communities varied with 
biogeographical location in the GI tract, with colon being the most diverse section. Firmicutes 
and Bacteroidetes were the dominant phyla in the GI tract of the young pig. Bacterial 
communities in both maternal colostrum and vaginal samples were significantly associated with 
those present in the GI tract, feces, and nasal passage of piglets. Treatment did not affect 
bacterial communities present in the piglet GI tract, however, the bacterial communities present 
iii 
 
in piglet fecal and nasal samples changed over time. The mRNA expression of TLRs and 
inflammatory cytokines changed (P < 0.05) with biogeographical location in the GI tract. Higher 
mRNA expression of TLRs and inflammatory cytokines was observed in ileum, ileum lymph 
nodes and peyer’s patches tissues. Although cross-fostering did not impact microbial 
communities in the piglet, this study suggests an impact of colostrum and maternal influence on 
the development of the microbiome of the piglet. This study revealed novel information about 
the distribution and expression patterns of TLRs and inflammatory cytokines in the GI tract of 
the young pig. 
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CHAPTER 1 
LITERATURE REVIEW 
 
Importance of Mucosal Microbial Communities in the Gastrointestinal Tract of the Neonatal 
Pig  
Fifty percent of preweaning mortality in piglets can be attributed to gastrointestinal and 
respiratory infections acquired during the first 72 hours after birth. The high levels of morbidity 
and mortality associated with infectious disease during this fragile stage of the production cycle 
is a serious cause of economic loss and welfare concern to the swine industry. In addition, 
infectious disease during the first weeks of life is an important driver of antimicrobial use in the 
swine production life cycle. In view of increasing concerns regarding antimicrobial residues in 
livestock-based food, and their potential role in the development of antimicrobial resistance, 
there is a growing interest in new strategies that could help increase host resilience, and so lower 
the frequency of disease during this vulnerable developmental period.  
 The role of colostrum in protection against neonatal infectious disease is well established. 
Cross-fostering is a management practice that is commonly used to maximize colostrum intake 
in the piglets. This entails the transfer of one or more piglets between litters, soon after birth, to 
equalize litter size and weights (Kirkden et al., 2013). The intake of an adequate volume of good 
quality colostrum during post-partum period is extremely beneficial to the health and 
development of the newborn piglet. Colostrum provides a rich source of nutrients for sustenance 
and growth, promotes epithelial health through the provision of cytokines and growth factors, 
and most importantly, supplies a wide range of soluble and cellular immune factors that provide 
local and systemic protection against infectious disease. Under optimal conditions, the duration 
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of immunological defense provided by the exogenous, maternally-derived, colostral immune 
factors, coincides with the development of the piglet’s own active, endogenous immune 
capability. The development of an adequate, effective and primed mucosal immune system 
involves the coordinated and measured exposure of the intestinal tract to environmental antigens. 
Recent studies have demonstrated a direct link between the developing gastrointestinal 
microbiota, and the health and disease susceptibility of growing pigs (Mann et al., 2014). The 
role of the gastrointestinal microbiota in nutrient utilization, intestinal permeability and immune 
development has been clearly demonstrated (Round and Mazmanian, 2009; Geuking et al., 2011; 
Ohnmacht et al., 2011; Schokker et al., 2014). While these previous studies provide strong 
evidence that the gastrointestinal microbiota contribute significantly to gut health and 
immunological fortitude (Collado et al., 2012), few studies have described the internal host and 
external management factors that might contribute to the development of a balanced microbiota 
and therefore establish a baseline between host immunity and microbiota. It is important to 
appreciate that the gastrointestinal tract is a complex ecosystem (Gordon and Pesti, 1971) 
comprised of a series of unique, anatomically-, and physiologically-distinct compartments, each 
of which represents a unique ecological niche. In view of the biogeographical complexity of the 
gastrointestinal  microbial community, and the fact that microbial community structure varies 
with time, environmental conditions and location (Dubos et al., 2005), it is interesting that many 
studies have focused on the fecal microbiota. While the colon harbors some of the most diverse 
microbial communities, it is evident that fecal samples are unlikely to be representative of the 
entire gastrointestinal tract, and it is well known that there is variation in microbial community 
structure along the gastrointestinal tract. Therefore further studies that provide an integrated 
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assessment of the microbial communities in different biogeographical locations along the 
alimentary tract are necessary. 
 
Analysis of Microbial Communities: 16SrRNA Sequencing 
The rapid growth in our understanding of the complexity and importance of the host-
microbiota relationship has been driven by the breathtaking advances in the availability and 
affordability of new, high speed, high throughput nucleotide sequencing technologies, and the 
development of bioinformatic tools that can be used to characterize and analyze large sequence 
data sets. Early studies of microbial communities relied on anaerobic culture-based techniques, 
which involved the isolation and growth of specific bacterial colonies, and the subsequent 
identification of strains by examining colony morphology, microscopic appearance, and 
fermentative capacities. While these traditional methods were successful in identifying a 
moderate number of bacterial species in the gastrointestinal tract, the growth and cultivation 
properties of some bacterial species meant that these approaches were limited in their capacity to 
characterize complex ecosystems (Handelsman, 2004; Dave et al., 2012). For instance, many 
culture methods favor the selective growth of some microorganisms over others, and thereby 
alter the natural composition of a community. Another drawback of culture-based techniques is 
the laborious and time-consuming nature of the procedures. This confers a practical limitation on 
the number of samples that can be efficiently processed, and so precludes the application of these 
techniques in large scale population studies (Leser et al., 2002).  
The first generation of culture-independent technologies was based on the amplification, 
fragmentation, denaturation, hybridization or sequence/size differentiation of strain-specific 
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DNA fragments. They included denaturing gel electrophoresis (DGGE), terminal restriction 
fragment length polymorphism (TRFLP), automated ribosomal intergenic spacer analysis 
(ARISA), and fluorescent in situ hybridization (FISH), and were commonly referred to as 
“fingerprinting” techniques. Although fingerprinting techniques brought a unique method and 
depth of microbial identification, they were criticized for their inability to provide species-level 
identification, and for their variable threshold limitations in detecting less abundant bacterial 
taxa. In addition, these methods continued to be laborious, and relatively expensive (Bent et al., 
2007). 
One extremely important development in the evolution of molecular-based approaches to 
bacterial identification, was the recognition of the inter-species variability of the 16S ribosomal 
RNA (rRNA) gene family (Woese, 1977). These genes encodes the 16S rRNA of the small 
ribosomal subunit, are present in all prokaryotes and archaea (Kim and Isaacson, 2015), and 
exhibit taxa-specific variation in their genomic sequence. For this reason, 16S rRNA gene 
sequences have become the most commonly used molecular markers for studying bacterial 
phylogeny and taxonomy, and can be used to provide even genus and species identification 
(Janda and Abbott, 2007). The universal presence of this gene family across prokaryotes means 
that 16S rRNA gene sequencing has also been useful for identifying unusual, non-cultivable, and 
phenotypically or biochemically indistinguishable strains. By incorporating a sequence-specific 
amplification step, investigators have been able to apply this approach to fastidious microbes that 
cannot be propagated in culture, and to help identify those that may be present in low abundance 
in a sample. The application of 16S rRNA gene sequencing to bacterial identification has also 
significantly reduced time and labor and has offered great opportunities for scalability in 
experimental design. As with all research tools, 16S rRNA gene sequencing has some significant 
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drawbacks when compared to culture-based techniques. For instance, in its simplest form the 
technique is non-quantitative, and cannot differentiate between the presence of live organisms 
and naked DNA. The broad sequencing approach also generates a large amount of data that 
requires detailed biostatistical analysis to foster reliable interpretation. Thus, while 16S rRNA 
sequencing-based approaches have certainly provided new insight in to the complexities of 
gastrointestinal microbiology, before using these techniques it is important to understand the 
caveats and potential drawbacks so that the results can lead to meaningful and accurate 
conclusions. 
 
Optimizing Quality and Reliability in the Study of Microbial Communities 
In any experimental system, investigator confidence in the study outcomes is ultimately 
determined by the reliability of the tools and the reproducibility of the results. The 16S rRNA 
gene sequencing-based techniques are often applied to the analysis of complex microbial 
communities in diverse environments, each of which can impact optimal sample processing, 
effective target amplification, and ultimately sequencing fidelity.  To avoid selective isolation 
and amplification of DNA from certain microbes, and to ensure that the nucleotide sequences 
generated during the process are representative of the taxa present in the original sample, careful 
attention must be given to sample processing and to primer design. Proper sample collection and 
complete DNA isolation are crucial determinants of the reliability of downstream procedures.  
Firstly, in view of the universal distribution of microbial nucleic acids in the 
environment, samples must be collected swiftly and hygienically. Following collection, careful 
and appropriate handling of the sample is essential for maintaining DNA integrity, and to prevent 
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the growth of opportunistic contaminants.  For instance, samples can be collected in to a solution 
containing nuclease inhibitors prior to subsequent sample dilution and DNA extraction. If the 
DNA extraction cannot be performed immediately, samples must be frozen on dry ice and stored 
at  −80 °C pending further processing (Highlander, 2012).  
Secondly, DNA must be isolated before attempting any downstream amplification or 
analysis. Currently, there are many commercially-available kits for DNA isolation, most of 
which utilize similar processes and protocols. An initial lysis of host and microbial cells is 
facilitated by chemical, enzymatic, and/or mechanical disruption of cell membranes. The 
efficiency and completeness of this lysis step has a significant impact in determining the extent 
and proportion of microbes that are identified in a particular microbial community (Highlander, 
2012). Traditionally, chloroform-based centrifugation methods were used to extract DNA, but 
there has been a more recent preference for the use of strong detergents in combination with 
physical disruption. For example, MO BIO Laboratories, Inc. (Carlsbad, CA) Power Soil® DNA 
isolation kits use Sodium dodecyl sulfate (SDS) as a strong detergent, and a bead beating method 
that lyses cells by collision of tiny glass beads with the sample. Alternatively, some approaches 
[e.g. Qiagen (Valencia, CA) QIAamp DNA Stool Kit)] use high temperature incubation with a 
detergent, followed by enzymatic treatment of the sample.  Isolated DNA is subsequently 
recovered from the lysate by fractionation on a spin column, or by ethanol precipitation. The 
final steps of any of these bench-top kits, is clean, purified DNA that is ready for PCR 
amplification and further analysis. 
The efficiency of amplicon detection and amplification is another key step in determining 
the quality of data that is generated by 16S rRNA gene sequencing-based techniques. Both of 
these steps are impacted by the effectiveness of primer selection or design.  The 16S rRNA gene 
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is present across all bacterial taxa, and contains a combination of highly conserved regions, 
interspersed with nine (V1-V9) hypervariable regions. The hypervariable regions contain the 
genus- and species-specific sequences and so are the main target sites for 16S rRNA gene-
sequence based approaches. By designing PCR-primer sets that recognize unique sequences 
within the hypervariable regions, amplicons from specific taxa of bacteria can be identified. 
Alternatively, by designing universal primers complementary to the highly conserved sequences 
that flank the hypervariable regions, all of the 16S rRNA genes present across different microbial 
domains, such as archaea or bacteria, will be amplified from a mixed microbial sample (Ludwig 
et al., 1994). Some universal primers are more competent than others, and certain longer 
hypervariable regions of the 16S rRNA gene reveal more information than others (Liu et al., 
2007; Schloss and Eisen, 2010). For instance, hypervariable regions V2 and V4 are often used 
because of their low error rates (Liu et al., 2007), and regions V3-V4 are known to offer greater 
taxonomical precision (Claesson et al., 2009). On the other hand, region V6 is rarely used, 
because it has been shown to produce confounding data regarding certain major phyla in the gut. 
Overall, there is no general consensus as to which 16S rRNA hypervariable region offers the 
most advantages. As a result, multiple regions are often used to help capture the full range of 
diversity of microorganisms in a sample (Sogin et al., 2006; Highlander, 2012). 
For many years full-length sequence analysis of cloned 16S rRNA genes were considered 
the gold standard for bacterial and archaeal classifications (Highlander, 2012). More recently, the 
amplification of partial hypervariable regions of the 16Sr RNA gene has been shown to provide 
comparable information to that described for full length sequence analysis at the genus level or 
higher (Kim, 2011). Modern DNA sequencing techniques, such as those termed high throughput, 
or next generation sequencing (NGS), have revolutionized the time efficiency and depth 
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effectiveness of microbial sequencing. For instance, NGS can generate reads greater than 1,000 
nucleotides. This allows for a more complete coverage of sequences, and thus exposes a greater 
breadth and diversity of microbes in a particular sample. The capacity and power of these new 
technologies has also fostered a decrease in time and cost for DNA sequencing. Currently, 
various platforms are available including the Ilumina HISeq 2000 and the Roche 454 FLX 
Titanium. They rely on pyrosequencing  techniques commonly known as “multiplexing”, a term 
referred to the addition of a unique tag or barcode that would identify the nucleotides by the 
amplitude of light emissions (Wooley et al., 2010). Barcoding amplicons increases the efficiency 
and decreases the cost of multiple microbial communities being sequenced simultaneously (Liu 
et al., 2007). While the use of NGS technology has certainly improved our ability to accurately 
describe and characterize microbial communities, its application still carries a number of 
potential pitfalls, the detailed discussion of which are beyond the scope of this paper.  It is 
important to recognize that although NGS technology makes sequencing costs affordable, 
amplicon preparation and library construction remains laborious and tedious. It is anticipated that 
the automatization of these procedures will gradually diminish expenses and processing time 
(Highlander, 2012).  
 
Bioinformatics Analysis and Taxonomical Classification 
Once the 16S rRNA sequence data has been generated, computational processing and 
adjustment of sequences remains a tremendous challenge, especially for researchers 
unacquainted with biostatical analysis. Several steps need to be taken to minimize errors in 
calculation and classification of reads. Quality filtering or “cleaning” of raw data is a crucial 
9 
 
element in the process of obtaining reliable results. Auspiciously, the computational industry 
have developed unique and convenient software to support researchers that lack programming or 
bioinformatics experience. Open-source bioinformatics pipelines are available that can assist in 
the complete or partial 16S rRNA analysis. MG-RAST, Mothur and Qiime (Caporaso et al., 
2010; Schloss and Eisen, 2010), are frequently used for quality checks and “trimming” of reads. 
Moreover, the detection and elimination of artifacts created during PCR amplification of 16S 
genes known as “chimeras” is essential to reliable representation of diversity. According to Haas 
et al. (2011), chimeras were responsible for the majority of problematic sequences and can be 
removed using tools such as Chimera Slayer (Haas et al., 2011), or UCHIME (Edgar et al., 
2011). It is important to eliminate chimeras since these are incline to magnify species abundance 
and are prone to errors in classification. Undoubtedly the future development of user friendly 
pipelines will help scientists and student researchers expand their knowledge and generate 
meaningful information. Trimmed and chimera free sequences are submitted to databases and 
aligned against known sequences for taxonomical classification. The most common databases 
are, Greengenes (Schloss, 2013), BLAST, SILVA (Pfeiffer et al., 2014) and the Ribosomal 
Database Project RDP (Looft et al., 2012), pipelines like Mothur and Qiime can accomplish 
various tasks, quality filtering, clustering of operational taxonomical units (OTU’s), taxonomic 
assignments and calculations of bacterial diversity in one package. Diversity estimates allow for 
the detection of minor changes in microbial composition within one particular community and 
between communities. 
 
Diversity Measurements 
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Alpha-diversity determines the diversity of microbes within a community; it exposes the 
richness denoted as the amount of OTUs in a sample. Common nonparametric measures of alpha 
diversity are the Chao1 estimator (Chao, 1984) based primarily on microbial richness and 
Shannon Index, grounded on the richness and closeness of bacterial groups in a community. 
Diversity between bacterial communities is known as beta-diversity (Whittaker, 1972), it can be 
determined using similarity indices; distance matrices are generated and later visualized as 
clusters (Highlander, 2012). Alternatively, Unique Fraction metric or UniFrac is a beta diversity 
measurement commonly used (Caporaso et al., 2010), it takes into consideration the different 
measures of similarity between sequences and calculates distance matrices than can be later used 
in PCoA (Principle Coordinate analysis). On the other hand, the Simpson Index, Bray Curtis 
Index and Morisita-Horn have similar ratios used to determine the number of shared species in 
relation to the entire population. In addition, other visualization aids such as hierarchical 
clustering and phylogenetic trees are commonly used to help describe beta-diversity (Highlander, 
2012). Approaching the challenges and reasonably scrutinizing the amount data generated by 
16S rRNA technology is critical to create meaningful information that will benefit production on 
the development of management strategies that will help shape up the developing microbiome of 
an individual. 
 
Current State of Knowledge: Gastrointestinal Microbiota of the Pig 
Considerable amount of literature has been published in humans on host-microbe 
interaction. The National Institute of Health (NIH) developed “The Human Microbiome Project” 
(Kim et al., 2011) that with the help of next generation sequencing technology (NGS) gave the 
scientific community a better understanding of the relationship  between the myriad of species 
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colonizing the human and the host immune system. Early colonizers once considered pathogens 
are now given a second chance, proving to be critical constituents and influencers of the intestine 
immune status (Marchesi, 2011; Collado et al., 2012).With these advances, new bacterial strains 
are revealed to coexist in places once considered “sterile” suggesting a deeper relationship of 
these microbes with the host (Reid et al., 2015). Recent research suggest that microbiota 
composition is among the most important factors influencing the development of diseases such 
as intestinal complications, cancer, obesity, asthma and diabetes just to mention a few (Isolauri, 
2012; Voreades et al., 2014). This early bacterial establishment is fundamental to the prevention 
of health problems and regulation of the immune system (Collado et al., 2012; Hansen et al., 
2012). In the same way microorganisms administered as probiotics have significantly improved 
quality of life (Reid et al., 2015), suggesting the potential use of microorganisms as health 
promoters. Throughout this review several examples regarding human microbiota and its 
relationship with the host will be exemplified. Although most of the current research is related to 
humans, several studies have documented the similarities between pigs and humans providing 
new insights into the pig’s relationship with bacterial communities and the impact of these 
microbial communities on animal performance. 
Anatomically pigs are similar to humans and for many years pigs have been used as 
model for human diseases (Xian et al., 2014; Zhao et al., 2015) as they share similar intestinal 
bacterial composition and dynamics from birth to maturity (Konstantinov et al., 2006; Thompson 
et al., 2008). At birth, the intestinal tract of newborn mammals is exposed to a cocktail of 
microorganisms; this freshly established microbiota will colonize and stabilize the undefined GI 
tract. In humans, the passage of antibodies from mother to offspring provides the immunological 
protection needed to deal with these new invaders (Rindsjö et al., 2010; Esposito et al., 2012). 
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The main disadvantage with pigs is they are born agammaglobulinemic, that is, there is no 
vertical transfer of immunoglobulins during gestation. Consequently, newborn pigs depend 
entirely on the sow’s colostrum for nutrient acquisition and immune protection (Decaluwé et al., 
2014). For this reason piglets are more susceptible to diseases, especially enteric and respiratory, 
during their first days of life (Tuchscherer et al., 2000) which in return bring great economic loss 
to the swine industry. One of the greatest challenges for the swine industry has been developing 
strategies to improve piglet’s performance and overall health. Most of these strategies involve 
the use of antibiotics in the diets as growth promoters and diarrhea reduction agents (Levesque et 
al., 2014; Kim and Isaacson, 2015). Little is known about the effects of antibiotics in the overall 
microbiota composition. However, recent welfare concerns regarding antibiotic residuals in food 
and antibiotic resistance has led to exploration of other areas of host-disease interaction. 
Intestinal microbiota in pigs can be influenced by many factors including environment, age, 
stress, and nutrition (Guo et al., 2008; Thompson et al., 2008; Levesque et al., 2014); and thus, 
the microbiota profile accomplished  by maturity will determine the well-being of the pig. A 
healthy microbiome is key to the individual health and changes in microbial composition can 
lead to disease (Voreades et al., 2014). Therefore, determining a healthy microbiome in the pig’s 
intestine and understanding its relationship with the host can lead to the development of better 
management practices in swine husbandry.  
 
Early Bacterial Inheritance and Immunological Contribution 
The exact origin of the mammalian intestinal microbiota is still unknown. According to 
Stark and Lee (1982), the mother’s microbiota is responsible for colonizing the offspring 
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gastrointestinal tract during the first years of life, thereafter, this microbiota is influenced by 
environmental factors and diet (Collado et al., 2012). Likewise Kim and Isaacson (2015) 
suggested, that initial microbiota is acquired through birth where the piglet is continuously 
exposed to the sow’s mucosal bacterial communities. In fact, recent studies have found microbes 
to be present in placental and fetal tissues (Reid et al., 2015) suggesting the uterus is not sterile 
after all, and microbes are metabolically and functionally important to the host. In a similar way, 
recent studies suggest that breastmilk provides the offspring with oligosaccharides  that modify 
bacterial composition (Donovan et al., 2012). Breastmilk also provides the newborn with key 
microbes beneficial for immune modulation, enhancement of epithelial integrity and absorption 
of nutrients (Collado et al., 2009; Fernández et al., 2013). Although it is still unknown how these 
microbes are capable of colonizing mammary glands, Martı́n et al. (2004) proposed a mechanism 
of regurgitation in the mother’s gut that allows these microbes to travel from the gut to the fetus 
and mammary glands. Additionally, Rescigno et al. (2001) and Macpherson and Uhr (2004) 
clarified that antigen presenting cells stimulate mucosal immunity by holding live bacteria inside 
and presenting it to the immune system, providing an opportunity for microbes to migrate.  
Breastmilk not only provides the individual with oligosaccharides necessary for growth, 
but also transmits microbes that are necessary to stimulate an immune response. Breastmilk has 
been discovered to contain Bifidobacteria, Lactobacilli and Staphylococci species (Martín et al., 
2003; Thompson et al., 2008; Isolauri, 2012; Fernández et al., 2013). Similarly, Mach et al. 
(2015) reported one hundred and eighty-two operational taxonomical units (OTUs) where shared 
between sow and piglet supporting the idea of bacterial strains passed down to the offspring via 
breastmilk. Interestingly, diet fortification with Lactobacillus in children generated a 46% 
decrease in intestinal diseases (Fernández et al., 2013). In a study Schokker et al. (2014) assigned 
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twenty piglets to three groups to determine whether stress and antibiotic usage had an effect on 
jejunal microbial composition and immune response. In their findings, the control group revealed 
higher immune response compared to the stress and antibiotic group. The authors correlated this 
response to a Lactobacillus increase. The other groups, antibiotic and stress administration, 
showed a significant reduction in Lactobacillus and immune response. Schokker et al. (2014) 
concluded that Lactobacillus is necessary to effectively stimulate the immune system and that 
antibiotic usage eliminates the initial pathogens and Lactobacillus strains, and thus, weakens the 
immune response. In a similar study Mach et al. (2015), found a strong relationship between 
microbiota and the immune response. In their findings, the presence of Prevotella, belonging to 
the phylum Bacteroidetes, was positively correlated with luminal secretory IgA, indicating a 
strong influence of gut microbiota in mucosal immunity. Xian et al. (2014) studied the effects of 
cross-fostering on cecal microbiota, finding better growth rate, and decreased Bacteroidetes in 
fostered piglets. Xian et al. (2014) concluded that artificial milk in fostered piglets changed 
microbial composition; however, the weight gain of cross-fostered piglets cannot be attributed to 
the microbial composition but to the nutritional richness of the artificial milk. This idea of milk 
source having an impact on gut microbiota is supported by the studies of Harmsen et al. (2000), 
Poroyko et al. (2010), and Li et al. (2012). Li et al. (2012) found an increase in Bifidobacterium 
and Clostridium in piglets suckling directly from the sow and an increase in Bacteroides vulgatus 
in piglets fed with formula. Surprisingly, Harmsen found similar results in fecal microbiota of 
children fed with formula compared to breast-milk. Breast-fed children have higher amount of 
Bifidobacteria, whereas Bacteroides in bottle-fed children equalized the amount of 
Bifidobacteria present. Additionally, Poroyko et al. (2010) found that Prevotella increased in 
sow fed piglets compared to formula-fed piglets in which Bacteroides was predominant. In this 
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same study, gene expression analysis revealed a significant increase in genes encoding amino 
acid metabolism enzymes in sow-fed piglets. Together these studies suggest a disreputable 
impact of milk source on the intestinal microbiota development. While these studies focus 
mainly on the impact of artificial vs. natural milk, cross-fostering impact should be further 
studied since piglets result in suckling milk from different sows (mother vs foster). It is 
important to study whether these sources alone, or a combination, will have a significant effect 
on the pig’s performance and overall health. 
 
Intestinal Bacterial Conformation and Displacement 
Most studies agree Firmicutes and Bacteroidetes accounts for the majority of taxa found 
in fecal samples of adult humans and pigs (Guo et al., 2008; Thompson et al., 2008; Claesson et 
al., 2009; Park et al., 2014; Mach et al., 2015; Zhao et al., 2015) followed by Fusobacteria, 
Proteobacteria and Actinobacteria. (Zhao et al., 2015). Mach et al. (2015) described the fecal 
microbiota of newborn piglets to be mainly represented by Bacteroides, Oscillibacter, 
Escherichia/Shigella, Lactobacillus and unclassified Ruminococcaceae genera. In contrast, older 
pigs included Acetivibrio, Dialister, Oribacterium, Succinivibrio and Prevotella genera which is 
similar to Kim et al. (2011) and Looft et al. (2012) findings. Although 16S rRNA sequencing 
provides substantial information about bacterial communities living in a determinate location, 
studies suggest intestinal microbiota fluctuates between location and age (Savage, 1977; Palmer 
et al., 2007; Kim et al., 2011). Hence, it is important that future studies take into consideration 
the shifts in microbial composition across the intestine and ages. For instance, studies conducted 
by Thompson et al. (2008) and Zhao et al. (2015) revealed the ratio of Firmicutes to 
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Bacteroidetes from feces of older pigs was higher than that of feces of newborn pigs. 
Metagenomics analysis of bacterial composition in small and large intestine reveals the large 
intestine microbiota has higher involvement in metabolic functions compared to small intestine 
(Zhao et al., 2015). 
Fecal sample is to some extent representative of the large intestine only and not 
representative of the entire GI tract (Zhao et al., 2015). Large intestine microbial species 
accounted for most of the species found in fecal samples and did not resemble the bacterial 
communities found in small intestine (Zhao et al., 2015).  This novel finding needs to be taken 
into consideration since most of the studies so far focus on fecal microbiota and not the entire GI 
tract. The initial microbiota established in a piglet will shift toward a mature microbiota 
approximately at six months of age according to Zhao et al. (2015). Thompson et al. (2008) 
studied at a species level the microbial shift in 24 piglets 36 days after birth. In their findings 
older pigs had a more stable microbiota that resembles that of their housing littermates and not 
their brothers, whereas newborn pigs had a dynamic composition that resembled their brothers. 
Thompson et al. (2008) concluded that before the establishment of a mature and definite 
microbiota, there is a gap in which the pig’s microbiome can be shaped and molded to produce a 
robust and more convenient individual. Thompson et al. (2008) also suggested further studies 
should focus on a species level since in their study differences could be clearly observed at a 
species level and not at a phyla or class level. Correspondingly Alain et al. (2014) studied the 
effect of diet, analyzing bacterial composition of fecal samples of pre-weaned and weaned 
piglets, in their results a shift in bacterial composition from Firmicutes to Bacteroidetes and an 
increase in Prevotella and Clostridium after weaning demonstrated that microbial communities 
can be influenced by diet or stress since weaning is a stressful event in the life of a pig. Likewise, 
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Levesque et al. (2014) found differences in mucosal bacterial composition in pigs fed with high 
and low energy diet, specially an increase of Clostridium consistent with age. Levesque et al. 
(2014) suggested microbial shift cannot be exclusively attributed to the diet but to the inclusion 
of antibiotic in the diet as well. Correspondingly, Hyeun Bum et al. (2012) revealed a prominent 
change at a genus level in fecal microbial composition of pigs treated with the bacteriostatic 
additive tylosin, a very well-known growth promoter, concluding that tylosin tends to accelerate 
microbial development.  
In conclusion, 16S rRNA sequencing has brought up sufficient evidence to indicate that 
gut microbiota is fundamental to the pig’s health and well-being. Moreover, that this microbiota 
is strongly influenced by external factors, especially the mother, a key influence upon the overall 
intestinal development. A healthy microbiome is key to the individual health and changes in 
microbial composition can lead to disease (Voreades et al., 2014). Therefore, determining a 
healthy microbiome in the pig’s intestine and understanding its relationship with the host, 
especially its contribution to the immune system, can lead to the development of better 
management practices and more robust pigs.  
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CHAPTER 2 
INFLUENCE OF MATERNAL MICROBIAL COMMUNITIES ON THE MUCOSAL 
MICROBIOME OF NEONATAL PIGS. 
 
INTRODUCTION 
Unlike human infants and puppies, at birth piglets have exceptionally restricted body 
reserves and scarcely get antibodies prenatally (Decaluwé et al., 2014). They are presented to 
unexpected changes outside their mom's body, experiencing severe ecological difficulties 
transitioning from a clean uterine environment into a complex and differing microbial 
environment. Many internal organs including the gastrointestinal (GI) tract are still relatively 
immature and not prepared for extra uterine life (Sangild et al., 2013). For this reason, 80% of 
preweaning mortality takes place during the perinatal period, mainly during the first 3 days of 
life (Tuchscherer et al., 2000). This a reason for great welfare concern and conveying incredible 
financial misfortunes to the swine enterprise (KilBride et al., 2014). Colostrum is still the only 
source piglets have to receive nutrients and protection (Decaluwé et al., 2014). This significance 
has led to the development of different management practices to enhance the amount of 
colostrum received by each piglet, thus reducing piglet morbidity and mortality. Cross-fostering, 
the transfer of piglets between dams during the farrowing process is a necessary practice to 
equalize the number of piglet between litters ensuring colostrum intake for their survival and 
growth (Kirkden et al., 2013). While these techniques are highly effective in promoting neonatal 
survival, there is little known about their effects on long term piglet performance.  
25 
 
We know in humans microorganisms are transferred from dam to offspring at parturition 
and during the neonatal period (Cerf-Bensussan and Gaboriau-Routhiau, 2010). Furthermore, 
breast milk once considered sterile has been demonstrated to be constant sources of microbes to 
the newborn gut (Collado et al., 2009; Fernández et al., 2013). In humans, microbes are 
transmitted in a personalized manner and play a key role in the maintenance of intestinal health 
and homeostasis, and therefore in the prevention of diseases (Fernández et al., 2013). Recently, 
associations between intestinal microbiota and increased number of intestinal diseases have been 
described in humans (de Vos and de Vos, 2012). For instance, crohn’s disease (Kaser et al., 
2010; Buttót et al., 2015), celiac disease (Nistal et al., 2012; Flass et al., 2015), and increased 
Clostridium difficile infections (Grehan et al., 2010; Khoruts et al., 2010) have been associated 
with intestinal microbiota. In pigs, microbiota also contributes to the development of the GI 
microbiota influencing the immune system and playing a casual role in the incidence of diarrhea 
(Zhao et al., 2015). Xian et al. (2014) reported effects of cross-fostering on cecal microbiota 
determining differences in microbiota between fostered piglets compared to their biological 
siblings.  
The number of studies determining the impact of cross-fostering on the GI microbiota is 
limited. It is our intention to increase knowledge in this area and to determine if this management 
practice could significantly impact the microbiota establishment during the early growing period. 
In view of the fact that the world is crashing into a post antibiotic era, we are in need of efficient 
management tools that will reduce the impact of disease without therapy and improve the 
nutritional needs of an increasing world population. Some important headway can be gained by 
taking a closer look at the interplay between the immune system, microbiota, and host. With the 
help of culture-independent molecular techniques we expect to have a better understanding and 
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assessment of the biodiversity of colostral microbiota and its relationship with the establishment 
and development of the gut microbiota in the growing pig. We hypothesize that cross-fostering 
piglets, and the timing of the cross-fostering, influences both the piglet’s immune system and its 
microbiota, which in turn, may have an impact on lifelong performance. Hence, the aim of this 
study was to determine the influence of maternal microbial communities on the mucosal 
microbiome of the young pig subjected to cross-fostering. 
 
MATERIALS AND METHODS 
Animal Management and Experimental Design 
Experimental procedures were approved by the University of Illinois Institutional Animal 
Care and Use Committee. Twenty-four piglets from 2 litter (12 pigs per litter), vaginally 
delivered from multiparous dams (White × Large) of the same parity on the same day, were 
enrolled in the study. Piglets were snatch farrowed at birth and placed in warm boxes under a 
heating lamp in the farrowing pen next to the sow. Daily physical examination including 
performance, appetite, and fecal score, were performed individually. Piglets were individually 
identified (ear tag) and stratified according gender, body weight, and good post-parturient health. 
Piglets were then randomly assigned to 1 of 3 treatment groups according to the source of 
colostrum and post-colostral milk feeding for 21 days, as follow: treatment 1 (n = 8), received 
colostrum and milk from their own dam; treatment 2 (n = 8), were litter exchanged at birth to 
receive colostrum from a foster dam for 24 – 36 hours and then returned to their own dam for 
post-colostral milk feeding the subsequent days; treatment 3 (n = 8), were litter exchanged at 
birth to receive colostrum and post-colostral milk from a foster dam, and they remained with the 
foster dam for the subsequent days. Each piglet was allowed to sucked colostrum for equivalent 
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times. The piglets were observed to exhibit vigorous teat sucking and subsequent satiation. No 
antibiotics were administered to the sows; E. coli/Clostridium bacteria vaccine was administered 
pre-farrowing. At birth, piglets received iron, male piglets were not castrated. Piglet’s tail was 
not docked at this time. None of the piglets were administered antibiotics during the 
experimental period. All piglets were weighted directly after birth and before being euthanized. 
 
Sample Collection 
At farrowing nasal, fecal and vaginal swabs (Pur-Wraps®, Puritan Medical Products, 
Gulford, Maine) were collected from each sow for microbiome analysis. Sows were restrained 
with the use of a snare and a mouth gag in order to collect the nasal samples. Nasal and fecal 
swabs were collected on day 0 and 21 from each piglet for microbiome analysis, following the 
same procedure as in the sow.  
At day 21 (a common weaning time in the pig industry), a group of 13 piglets were 
humanely euthanized. After opening the visceral cavity, esophagus and rectum were clamped to 
avoid spilling of gastrointestinal digesta and thus contamination of other intestinal parts. 
Immediately after removing the gastrointestinal tract from the visceral cavity, standardized 
locations of the stomach, ileum and mid-colon (divided into 3 equal parts) were exposed with 
sterile instruments and luminal contents were collected with a swab. Luminal sites were later 
rigorously washed several times with sterile phosphate-buffered saline (Mediatech, Inc., 
Manassas, VA) to remove remains of free floating bacteria and proceed to collect mucosal 
content. Mucosal contents from the stomach, ileum, colon, middle jejunum, distal jejunum, 
proximal jejunum, and duodenum were collected aseptically by scraping off the mucosa using 
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number 20 surgical blades (Bard-Parker, Aspen Surgical™ Products, Caledonia, MI). Mucosal 
scrapings were collected in cryovials and kept on dry ice until being stored at −20 °C.  A 2-cm2 
portion of the tissue was excised and placed in a tube with 5 mL RNA LATER® (Sigma-
Aldrich, Saint Louis, MO) for qPCR analysis. Mucosal scrapings, luminal swabs, and tissue 
samples were snap frozen and then stored at −20 °C. The remainder of the animals (n = 11) were 
penned together at weaning (day 21) and grown to market weight in pens that only contain study 
pigs. They were reared in a room with their farrowing cohort and cared for by farm staff 
according to standard practices. 
 
DNA Isolation 
Genomic DNA was extracted from 0.25 grams of mucosal scrapings (stomach, ileum, 
colon, duodenum, and middle, distal and proximal jejunum) and swab tips from fecal, luminal, 
skin and respiratory samples using the MOBIO Power Fecal DNA Isolation Kit (MO BIO 
Laboratories, INC., Carlsbad, CA) following the manufacturer’s protocol. Samples were 
homogenized using the Bullet BlenderTM (Next Advance; Averill Park, NY) following the 
manufacturer’s recommendation. Colostrum DNA was extracted using the Qiagen DNA 
Isolation Kit (Hilden, Germany) according to manufacture guidelines.  The DNA concentration 
was determined with the Nanodrop ND-1000 UV-Vis spectrophotometer (Nanodrop 
Technologies, Rockland, DE) at wavelengths of 260 and 280 nm to assess the purity of the DNA. 
Samples with a ratio between 1.9 and 2.15 were considered acceptable (Nanodrop Technical 
Note). DNA integrity was assessed by running a 2% agarose gel (Sigma-Aldrich, Saint Louis, 
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MO) with SYBR Safe DNA Gel Stain (Invitrogen, Grand Island, NY).  Extracted DNA was 
stored at −20 °C.  
 
16S rRNA Gene Amplification and Sequencing  
16S rRNA genes were amplified using specific primers, F28 (5'-
GAGTTTGATCNTGGCTCAG) and V1-V3 R519 (5'-GTNTTACNGCGGCKGCTG), to target 
the V1-V3 hypervariable region. After DNA extraction and quality assessment, 40 µl of DNA 
from each were place in 96 well- plate according to the sequencing laboratory directions. 
Samples were sent to the biotechnology center in dry ice and arrived within 30 minutes. The 
PCR products were sequenced using Illumina MiSeqV3 platform (Ilumina, San Diego, CA) 
sequencing combined with Fluidigm Access Array. Amplification technique was performed at 
the W. M. Keck Center for Comparative and Functional Genomics (University of Illinois, 
Urbana, IL). The fluidigm constructed library was quantitated by qPCR and sequenced on one 
MiSeq flowcell for 301 cycles from each end of the fragments using a MiSeq 600-cycle 
sequencing kit (version 3). Fastq files were generated and demultiplexed with the bcl2fastq 
v1.8.4. Conversion PhiX DNA was used as a spike-in control for MiSeq runs. 
 
Phylogenetic Assignment and Processing of Sequenced Reads  
All the total reads obtained from the sequences [230 samples; 23,870,950 reads, as 
follow: fecal samples generated 1,811, 829 sequences (median = 69,987; range=5,288-192,566), 
respiratory samples generated 1,388,305 sequences (median = 63,801; range= 4,288-156,835), 
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intestinal samples generated 8,816,931 sequences (median = 375,529,094; range= 15,025-
183,367), and sow samples collected generated 379,752 (median = 61,399; range= 6,661-90,947) 
sequences], were processed together using Illinois Mayo Taxon Organization from RNA Dataset 
Operations (IM-Tornado; v 2.0.3.2) (Jeraldo et al., 2014) to generate Operational Taxonomical 
Units (OTU), and subsequently clustered into 52,642 OTUs based on 97% similarity using 
Greengenes as a reference database. Following sequencing, 16S rRNA gene reads were assessed 
for quality, only reads that were longer than cutoff lengths were processed for OTU picking. 
Quality scores were generated using Fast QC. All reads were initially 300 bases long, the number 
of bases covered by read1 and read2 were longer than the fragment length and therefore there 
was partial overlap between read1 and read2. To be able to run IM-TORNADO’s regular 
pipeline, this overlap needed to be removed. For this, trimmomatic 
(http://www.usadellab.org/cms/?page=trimmomatic) was run to trim primer sequences at the 5' 
end and then cropped read1 to 250 and read2 to 200 bases long so that there will not be any 
overlap between read1 and read2. All the data preprocessed as described above was run with IM-
TORNADO for the regionV1V3. 
 
Diversity Indices 
Alpha diversity analysis was run to know diversity within the samples or categories, 
while beta diversity analysis was run to determine diversity between samples or groups. The 
OTU table was generated by IM-TORNADO pipeline and the mapping file was required for this 
analysis. Quantitative insights into Microbial Ecology (QIIME; http://qiime.org/) was used to 
first convert Biological Observation Matrix (BIOM) file to text format file, and create a 
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summary of OTU table generated by IM-TORNADO to finally run alpha and beta diversity 
analysis scripts. Alpha diversity at several different rarefactions was calculated and then the 
results from all different rarefactions were collated, and then plotted as alpha rarefaction plots by 
QIIME. By default, the minimum rarefaction depth is 10 and the maximum is median sequence 
over sample count. These defaults are useful for determining whether you have enough depth in 
your samples to accurately capture all the diversity present. If the lines eventually plateau, then 
there is enough depth, otherwise the samples may not have enough depth to capture all possible 
OTUs present. QIIME was used to calculate beta diversity values and create a distance matrix 
that could be later visualized. Chao1, observed species, PD whole tree and Shannon diversity 
index were calculated with QIIME.   
 
Statistical Analysis 
Statistical analyses of bacterial communities were performed using JMP 12.2 (SAS 
Institute Inc., Cary, NC). The relative abundance of fecal bacterial taxa for each treatment group 
were compared using general linear models (ANOVA). The model for bacterial communities in 
the piglet GI tract contained the fixed effect of treatment and GI site. The model for bacterial 
communities in piglet nasal and fecal samples contained the fixed effects of treatment and time. 
The relative abundances of different bacterial taxa in each sample as covariates and sampling 
days as the categorical variable were used in stepwise discriminant analysis as described by 
Zinicola et al. (2015). In this way the microbial shift from day 1 until day 21 was illustrated 
using canonical loading plots. In our study, variables were removed in a stepwise manner until 
only variables with a P > 0.001 were retained in the final model. Fastq data obtained as results of 
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sequencing samples of sows and piglets were uploaded to the sequence read archive (SRA) on 
National Center for Biotechnology Information (NCBI) web page tool 
(http://www.ncbi.nlm.nih.gov/sra) to make the files available for a public database (BioProject 
ID accession number PRJNA319360). To assess the association between bacteria genera, present 
in colostrum, vaginal, and fecal samples of the sow with bacteria genera present in the GI tract, 
fecal, and nasal samples of the young pig regression and correlation analyses were performed 
using the REG and CORR procedures of SAS (v9.4 Institute Inc., Cary, NC). Statistical 
significance was declared at P ≤ 0.05 and trends toward significance effects were noted when 
0.05 < P ≤ 0.10. 
 
RESULTS 
Microbial Diversity 
Reads were pooled and analyzed using various diversity metrics for each group to 
calculate diversity of microbial communities. The detailed diversity estimates can be found in 
Table 2.1. Metrics used were Chao1 index of microbial richness, observed species, and Shannon 
index of biodiversity. The diversity indices used represent how many different taxa were present 
in a sample, higher numbers indicate higher diversity. Indices of biodiversity showed higher 
number of microbial communities in the colon section of GI tract and in treatment 1 (Figure 2.1). 
Additionally, fecal and nasal samples of day 21 showed higher microbial diversity compared to 
samples of early piglet age (Figure 2.2). 
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Relative Abundance of Bacterial Phyla in the Gastrointestinal Tract of Young Pigs 
The OTUs were classified into 18 bacterial phyla, of these, 5 phyla were ≥ 1%. 
Comparison of relative abundance at the phylum level revealed that the major phyla dominating 
the microbiome were Firmicutes 64%, Bacteroidetes 16%, Proteobacteria 12%, Spirochaetes 
4%, and Fusobacteria 1% (Figure 2.3). No differences (P > 0.05) on the aforementioned phyla 
were found between treatments.  However, their relative abundance was different (P < 0.05) 
among GI sites (Figure 2.3). Firmicutes were highly abundant through the GI tract. Greater 
relative abundance of Bacteroidetes was found in the colon compared to the other GI sites. 
Proteobacteria was observed along the GI tract with no significant differences (P > 0.05) 
between sites. Although statistical differences were not observed among GI sites, reduced 
relative abundance of Proteobacteria was observed in colon. Spirochaetes and Fusobacteria 
were not as predominant compared to the others abovementioned bacteria phyla. However, 
relative abundance of Spirochaetes was predominant in colon, especially in that of treatment 3. 
 
Relative Abundance of Bacterial Phyla in Fecal Samples of Young Pigs 
Relative abundance of bacterial phyla in fecal samples was not affected (P > 0.05) by 
treatment (Figure 2.4). However, relative abundance changed (P < 0.05) over time. The relative 
abundance of Firmicutes was predominant at day 0 but abruptly decreased at day 21. The 
opposite occurred with Proteobacteria, Spirochaetes, and Bacteroidetes which relative 
abundance was lower at day 0 but significantly increased at day 21. 
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Relative Abundance of Bacterial Phyla in Nasal Samples of Young Pigs 
In nasal samples, relative abundance of bacterial phyla was not affected (P > 0.05) by 
treatment (Figure 2.5). However, relative abundance changed over time (P < 0.05). Firmicutes 
was highly present at day 0, but significantly decreased at day 21. The opposite occurred for 
Proteobacteria, which had lower relative abundance at day 0 but significantly increased at day 
21. Similar tendency was observed for Bacteroidetes, although, this phylum was not as abundant 
as Proteobacteria at day 21. As we went deeper in taxonomy, we were able to see greater 
variation between sites, successively all samples were assessed at a genus level. 
 
Abundance of Bacterial Genera Present in the Sows: Colostrum, Vaginal, and Fecal Samples 
Bacterial communities present in colostrum, vaginal, and fecal samples collected from the 
sows were classified into 104 predominant bacterial genera, of which, 23 for colostrum, 21 for 
vaginal, and 17 for fecal were ≥ 1% (Figure 2.6). Lactobacillus and Clostridium were highly 
abundant in colostrum (38 and 24%, respectively) and vaginal (52 and 13%, respectively) 
samples. Similarly, in fecal samples Lactobacillus (56%), Campylobacter (7%), and 
Anaerococcus (5%) were the predominant genera. A large number of bacteria genera 
(Allobaculum, Aminiphilus, Anaerovorax, Anoxynatronum, Barnesiella, Butyricicoccus, 
Butyricimonas, Cloacibacillus, Coprococcus, Corynebacterium, Escherichia/Shigella, 
Eubacterium, Finegold, Flavonifractor, Gilvibacter, Hydrogenobaculum, Oscillibacter, 
Peptoniphilus, Phascolarctobacterium, Porphyromonas, Prevotella, Pseudoflavonifractor, 
Pseudomonas, Ruminococcus, Saccharofermentans, Staphylococcus, Streptococcus, 
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Succinivibrio, Syntrophaceticus, Tannerella, Turicibacter, Veillonella, and Xylanibacter) were 
present in less than 5% in colostrum, vaginal, and fecal samples (Figure 2.6). 
 
Abundance of Bacterial Genera in the Gastrointestinal Tract Young Pigs 
Bacterial communities present in the GI tract of young pigs were classified into 178 
bacterial genera, of which, 40 were ≥ 1%. Treatment did not have a significant (P > 0.10) effect 
in bacterial communities present in the GI tract, except for Clostridium, Faecalibacterium, and 
Haemophilus (<1%) that were different (P < 0.05) among treatment (Table 2.2). Higher 
percentage of Clostridium and Haemophilus were present in the GI tract of treatment 1 and 
treatment 2 compared to treatment 3, whereas Faecalibacterium was higher in treatment 1 
compared to treatment 2 and treatment 3 (Table 3). Bacterial communities were different among 
GI sites (P < 0.05), differences between GI sites and treatment are illustrated Figure 2.7. The 
stomach, duodenum, jejunum, ileum, and colon accounted for 17, 19, 12, 24, and 28% of total 
bacterial genera present in the GI tract, respectively. Lactobacillus and Clostridium were the 
predominant genera in stomach (51 and 11%, respectively), duodenum (61 and 65%, 
respectively), jejunum (56 and 24%, respectively), and ileum (15 and 34%, respectively). Colon 
was the most diverse section of the GI tract and no particular predominance of bacterial genera 
was observed (Figure 2.7).  However, Treponema was mostly present in colon of treatment 3 
(35%) compared to treatment 1 (< 1%) and treatment 2 (1%), and increased in jejunum (10%) 
and ileum (15%) of treatment 3. Tannerella was mostly present in colon (10 – 15%) and ileum 
(20%) in treatment 3. In a similar way, Prevotella was predominant in colon (15 – 20%) 
meanwhile in the rest of the GI tract it was present < 1%. Ruminococcus (8%) and 
Sphaerochaeta (5%) were mostly present in colon.  Bacterial communities present in the 
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stomach, jejunum, and duodenum were more similar to each other than those present in ileum 
and colon, as represented in Figure 2.8. 
 
Abundance of Bacterial Genera in Fecal Samples of Young Pigs 
Bacterial communities present in fecal samples from piglets at day 0 and 21 were 
classified into 142 genera, of which, 18 were greater than 1%. Bacterial genera in fecal samples 
other than Campylobacter and Fluviicola were not affected (P > 0.05) by treatment (Table 2.3). 
However, abundance of these two genera was below 5%. While Campylobacter was mostly 
present in treatment 2 (5%) compared to treatment 1 (< 1%) and treatment 3 (1%), Fluviicola 
was present in treatment 1 (1%) only. Regardless of treatment, bacteria genera predominant in 
fecal samples were Lactobacillus (16%), Clostridium (15%), Treponema (12%), and Bacteroides 
(10%) with the rest accounting < 10% (Figure 2.9). Bacteria communities in fecal samples 
changed (P < 0.05) over time (Figure 2.9). While Lactobacillus and Clostridium were the 
predominant genera at day 0 (34 and 20%, respectively), their abundance decreased to 5% at day 
21. On the other hand, Bacteroidetes increased from 3% at day 0 to 18% at day 21. Although 
other bacteria genera (Butyricicoccus, Campylobacter, Fluviicola, and Turicibacter) changed 
significantly from day 0 to day 21, their abundance was less than 5%. 
 
Abundance of Bacterial Genera in Nasal Samples of Young Pigs 
Bacterial communities present in nasal samples from piglets at day 0 and 21 were 
classified into 156 genera, of which, 22 were greater than 1%. Treatment did not have a 
significant effect (P > 0.10) in bacterial communities present in nasal samples, however, 
bacterial communities changed over time (Table 2.4). While Clostridium and Lactobacillus were 
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the predominant genera at day 0 (25 and 24%, respectively), their abundance completely 
decreased to less than 1% at day 21 (Figure 2.10). On the other hand, Moraxella increased from 
11% at day 7 to 78% at day 21 (Figure 2.10). Although other bacteria genera (Aerococcus, 
Aminiphilus, Anaerotruncus, Butyricicoccus, Clostridium, Coprococcus, Escherichia/Shigella, 
Ethanoligenens, Eubacterium, Facklamia, Flavonifractor, Megasphaera, Oscillibacter, 
Psychrobacter, Saccharofermentans, and Syntrophaceticus Turicibacter) changed significantly 
from day 0 to day 21, their abundance was less than 5% (Figure 2.10).  
 
Association between Bacterial Genera Present in the Sow and in the Young Pigs 
 Bacterial genera present in the GI tract of the piglet had the highest correlation with 
bacterial genera present in colostrum (r = 0.93; P <0.0001; R
2
 = 0.88), vaginal (r = 0.99; P 
<0.0001; R
2
 = 0.99), and fecal samples (r = 0.96; P <0.0001; R
2
 = 0.91) of the sow (Table 2.5). 
Although lower than the correlations of the GI tract, bacteria genera present in fecal samples of 
the piglet had high correlation with bacteria genera present in colostrum (r = 0.72; P <0.0001; R
2
 
= 0.51), vaginal (r = 0.65; P <0.0001; R
2
 = 0.41), and fecal samples (r = 0.57; P <0.0001; R
2
 = 
0.31) of the sow (Table 1). The lowest correlations were observed between bacteria genera 
present in piglets nasal samples with bacteria genera present in colostrum (r = 0.50; P <0.0001; 
R
2
 = 0.24), vaginal (r = 0.42; P <0.0001; R
2
 = 0.17), and fecal samples (r = 0.34; P <0.0001; R
2
 
= 0.11) of the sow (Table 2). Surprisingly, the highest correlation was between bacteria genera 
present in vaginal samples of the sow and the bacteria genera present in the GI tract of the young 
piglet. 
 
 
38 
 
DISCUSSION 
The influence of gut microbiota in gastrointestinal diseases has successfully been 
demonstrated through next generation sequencing. Likewise, these techniques have revealed the 
importance of gut microbiota in animal gut. Clarifying normal bacterial communities versus 
pathogenic bacteria in the pig is pivotal for establishing differences associated with disease.  In 
our study we used 16S rRNA sequencing to determine if cross-fostering piglets influenced the 
microbial communities in the developing piglet gut microbiome. The overall goal was to assess 
the influence of maternal microbial communities on the mucosal microbiome of the young pig 
subjected to cross-fostering. The current study found that the dominant phyla in the 
gastrointestinal tract of the young pig were Firmicutes, Bacteroidetes, followed by Fusobacteria, 
Proteobacteria, and Actinobacteria. These results are in accord with recent studies indicating the 
predominance of these particular phyla (Ley, 2008; Poroyko et al., 2010; Schmidt et al., 2011; 
Schokker et al., 2014). Additionally, prior studies have noted the role of microbes present in the 
mother responsible for colonizing the gastrointestinal tract of the young pig (Stark and Lee, 
1982). Surprisingly, in our study microbial profiles of vaginal, colostrum, and feces of the sow 
were similar between each other with a predominance of the genera Lactobacillus and 
Clostridium. These genera were also found in high abundance in the gastrointestinal tract of the 
young pig. A possible explanation for this is that Lactobacillus and Clostridium were highly 
abundant in colostrum and vaginal samples of the sow and these may contribute to the 
colonization of the intestine of the young pig. This finding, while preliminary, suggests there is 
an influence of maternal colostral and vaginal microbial communities on the mucosal bacterial 
populations of the GI tract of the young pig. Additionally, influence of maternal microbiome 
seems to be highest soon after birth, but appears to diminish with time. These results are 
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consistent with those of Mach et al. (2015) where they reported bacterial genera being shared 
between sow and piglet supporting the idea of bacterial strains passed down to the offspring via 
breastmilk. In our study results demonstrated that the composition of fecal and nasal microbiota 
changed as the pigs aged. Microbial profiles of fecal and nasal samples of newborn pigs were 
significantly different from older pigs (21 days of age). These results are consistent with those of 
Thompson et al. (2008) who agreed that bacterial ratio changes with age and more specifically 
that Bacteroidetes in feces increased with age. This matches our results in which we found an 
increase in Bacteroidetes at day 21. 
Our results suggest that microbes vary throughout the GI tract, these results are in accord 
with Isaacson and Kim (2012), microbial communities found in the small intestine (jejunum, 
duodenum, ileum) were different than that found in the large intestine (colon). Colon was very 
diverse and no predominance of genera was observed, however, Treponema was most abundant 
in colon specifically in treatment 3. Treponema are fastidious and difficult to cultivate, it may be 
found in vaginal, oral, and GI tract of humans, animals and insects. Recent identification of 
Treponema relies solely on metagenomics techniques (Evans et al., 2011). The finding of 
Treponema in our study can provide some insight into commensal and pathogenic Treponemas, 
although further phylogenetic studies are necessary to elucidate this, and be used as biomarkers 
for future diseases. According to DiBaise et al. (2008) these locations have different metabolic 
functions and therefore the microbes vary between locations. For instance, the small intestine is 
in charge of digestibility and absorption, meanwhile large intestine contains large number of 
bacteria in charge of fermentation. Furthermore, changes in gut microbiota have been associated 
with caloric intake and body weight  (Park et al., 2014) as well as host genetics (Ley, 2008; 
Benson et al., 2010). In our study, we did not take into consideration body weight or genetics; it 
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is possible this may contribute to the changes in microbial communities. In contrast to previous 
findings (Zhao et al., 2015), Firmicutes was more abundant in the small intestine and 
Bacteroidetes was increased in the large intestine. Fecal samples showed higher abundance of 
Bacteroidetes at day 21. It is possible therefore, that feces were mainly representative of the 
large intestine and not representative of the entire GI tract (Zhao et al., 2015). Proteobacteria 
and Actinobacteria were present mainly in nasal samples. In the GI tract, treatment had an effect 
on Clostridium, Faecalibacterium, and Haemophilus, it is possible therefore, that cross-fostering 
did impact the trajectory of certain genera in the development of the mucosal microbiome. 
Although not statistically different some genera were present on treatment 3 that were not 
present on treatment 1 or treatment 2 such is the case of Verrucomicrobia. According to Dubourg 
et al. (2013), the prevalence of this particular phyla and Synergistetes may suggest dysbiosis and 
a risk to the health of the pig’s gut. In our study Synergistetes remained steady especially in the 
colon. Vianna et al. (2007) found that although this phylum is normal microbiota, its high 
abundance could potentially play a role in periodontal disease. Although in this study we could 
not determine a difference and/or association between treatments and these two phyla, the 
prevalence and quantity of these bacteria may be suggestive of a dysbiotic gut. 
 
CONCLUSION 
This project is a unique assessment of microbial populations within the context of cross 
fostering and efforts were made to address possible confounding factors and maintain 
conclusions within limitations of the experimental design. Overall the results from this study 
revealed the predominance of the phylum Firmicutes and Bacteroidetes in the gastrointestinal 
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tract of the young pig, the gastrointestinal tract of the young pig is highly diverse specially the 
colon. Most of the variability was noticed at a genus level, meaning that bacteria present in a low 
quantity could be key microbes to understand the functions of the microbiome and its 
relationship with disease.  There were a low number of pathogenic species (<1%) that could 
potentially cause disease, this needs to be further investigated. Furthermore, there is an influence 
of maternal microbial populations on the development of the newborn pig and this microbiota 
continues to change as the pig grows. Changes in microbial communities although not addressed 
in this study may be caused by a variety of factors, including environment, antibiotic, stress and 
genetics. The vast majority of gut microbiota studies have focused on the descriptions of the 
bacteria present in the gut. However, future trials should assess the dynamics of gut microbiota, 
its translation to function and the effect of these functions on health and well-being. This will 
likely provide researchers with crucial information that will be used to improve productivity in 
food animals. The microorganisms present in different GI sites resemble those present in 
colostrum and vaginal. This allows us to hypothesize a strong influence of colostrum and vaginal 
in the development of the gastrointestinal microbiota of the newborn piglet. Techniques such as 
metatranscriptomics and metabolomics will be needed to reveal causes and effects of microbial 
shifts in the gut and could potentially reveal biomarkers of disease before clinical symptoms 
appear. 
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Table 2.1. Microbial diversity estimates 
Piglet GI
1
 site Shannon
2
 SD
3
 
 
Chao
4
 SD 
 
Observed sp
5
 SD 
Piglet GI site 
        
 
Stomach 5.33 0.92 
 
88.0 1.39 
 
86.0 5.87 
 
Duodenum 4.86 0.97 
 
66.3 6.38 
 
74.7 8.81 
 
Jejunum 5.26 0.63 
 
86.9 1.32 
 
68.8 2.37 
 
Ileum 5.31 0.86 
 
100.6 2.23 
 
75.0 3.22 
 
Colon 6.90 0.65 
 
106.5 4.79 
 
135.7 9.96 
Piglet 
        
 
Fecal 3.76 0.32 
 
100.1 1.25 
 
74.4 3.96 
 
Nasal 4.19 1.52 
 
103.6 0.25 
 
135.6 9.70 
Piglet fecal by day 
        
 
0 3.78 0.56 
 
65.3 0.52 
 
66.0 7.56 
 
21 4.26 0.76 
 
105.6 3.56 
 
139.0 9.57 
Piglet nasal by day 
        
 
0 3.13 0.57 
 
28.0 5.23 
 
46.8 8.56 
 
21 4.36 0.60 
 
32.6 6.24 
 
105.6 3.26 
Sow 
        
 
Colostrum 4.63 0.30 
 
103.7 8.90 
 
120.1 5.20 
 
Fecal 3.79 0.68 
 
172.2 9.60 
 
120.8 10.26 
 
Vaginal 4.31 0.24 
 
126.5 3.23 
 
147.7 8.39 
Overall 
        
 
Sow 4.05 0.62 
 
157.6 4.56 
 
137.6 8.45 
 
Treatment 1 4.02 1.12 
 
106.8 5.11 
 
81.7 4.65 
 
Treatment 2 3.86 1.12 
 
96.2 5.23 
 
76.5 0.57 
 
Treatment 3 3.86 0.88 
 
92.7 4.56 
 
67.2 1.24 
Overall day 
        
 
0 4.23 0.50 
 
121.3 1.24 
 
86.2 0.32 
 
21 5.79 1.08 
 
95.2 2.45 
 
173.3 3.78 
1 
Gastrointestinal. 
2
 Shannon index of biodiversity. 
3
 Standard deviation. 
4
 Chao 1 index of microbial richness. 
5
 Observed species. 
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Table 2.2. Bacteria genera present in the different gastrointestinal (GI) tract of piglets in treatment 1, 2, and 3 
Phylum Genus 
Treatment
1
 
SEM
2
 
GI Site 
SEM 
P
3
 
1 2 3 Colon Duodenum Ileum Jejunum Stomach Trt GI site 
Bacteroidetes Alloprevotella 1.31 1.83 0.59 0.34 1.74 0.79 0.31 0.68 3.02 0.52 0.09 0.02 
Firmicutes Anaerostipes 0.16 0.18 0.03 0.06 0.44 0.10 0.07 0.06 0.14 0.09 0.19 0.03 
Bacteriodetes Bacteroides 2.94 1.37 1.74 0.74 5.58 1.86 4.34 1.68 1.22 1.13 0.35 0.05 
Bacteroidetes Bergeyella 1.03 0.80 0.50 0.18 0.25 1.57 0.26 0.61 2.45 0.28 0.19 0.001 
Firmicutes Clostridium 16.2 21.0 4.40 4.05 6.72 7.94 29.1 24.8 12.5 6.18 0.05 0.05 
Firmicutes Dorea 0.36 0.24 0.58 0.17 1.24 0.24 -0.01 0.12 0.21 0.25 0.38 0.02 
Firmicutes Faecalibacterium 0.55 0.09 0.01 0.12 0.67 0.55 0.70 0.39 0.43 0.19 0.03 0.60 
Proteobacteria Haemophilus 0.14 0.26 0.05 0.06 0.02 0.05 0.21 0.09 0.31 0.09 0.05 0.12 
Bacteriodetes Hallella 0.13 0.14 0.14 0.04 0.49 0.00 0.12 0.05 0.01 0.06 0.98 0.001 
Firmicutes Lactobacillus 37.1 32.3 43.4 4.96 4.00 61.9 14.5 51.8 53.4 7.58 0.36 0.001 
Proteobacteria Moraxella 3.19 1.43 2.30 0.75 0.89 5.24 0.89 2.67 6.28 1.15 0.31 0.01 
Proteobacteria Paraperlucidibaca 0.28 0.09 0.10 0.07 0.13 0.24 0.13 0.34 0.58 0.11 0.15 0.04 
Bacteriodetes Porphyromonas 1.04 0.90 1.05 0.20 0.04 1.06 0.04 0.76 3.30 0.31 0.85 0.001 
Bacteroidetes Prevotella 2.24 2.0 2.55 0.63 9.58 0.36 0.44 0.27 0.54 0.97 0.83 0.001 
Firmicutes Ruminococcus 1.54 1.76 2.47 0.73 5.39 0.97 0.83 0.43 0.05 1.11 0.65 0.02 
Spirochaetes Treponema 1.45 0.67 2.02 0.40 5.65 0.14 0.92 0.26 0.26 0.61 0.11 0.0002 
Fusobacteria Streptobacillus 0.07 0.11 0.11 0.03 -0.03 -0.01 -0.03 0.02 0.40 0.05 0.59 0.003 
Firmicutes Streptococcus 1.01 0.99 0.60 0.23 0.17 2.35 0.33 0.85 1.37 0.35 0.40 0.01 
Firmicutes Turicibacter 0.66 0.92 0.61 0.21 0.08 0.60 0.63 0.36 1.61 0.32 0.54 0.03 
1 
Treatment: 1 = litter received colostrum and post-colostrum milk feeding from their own dam; 2 = litter exchanged at birth to receive 
colostrum from a foster dam and then returned to their own dam for post-colostral milk feeding for the subsequent days; and 3 = litter 
exchanged at birth to receive colostrum and post-colostrum milk feeding from a foster dam, they remained with the foster dam for the 
subsequent days.
2
 Greatest standard error of mean (SEM).
3
 Trt = treatment; GI site = gastrointestinal site 
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Table 2.3. Bacteria genera present in fecal samples of treatment 1, 2, and 3 at day 0 and 21 
Phyla Genera 
Treatment
1
 
SEM
2
 
Day 
SEM 
P
3
 
1 2 3 0 21 Trt Day 
Bacteroidetes Bacteroides 2.73 5.10 -2.09 5.09 2.73 17.91 5.09 0.40 0.09 
Firmicutes Butyricicoccus 1.53 1.03 1.00 0.33 1.53 0.35 0.33 0.40 0.06 
Proteobacteria Campylobacter -0.39 4.56 -0.02 0.47 -0.39 1.31 0.47 0.02 0.06 
Firmicutes Clostridium 19.99 26.46 19.78 1.96 20.0 4.78 1.96 0.15 0.01 
Bacteroidetes Fluviicola 0.46 -0.02 -0.05 0.07 0.46 0.56 0.07 0.04 0.20 
Firmicutes Lactobacillus 34 24 37 5.09 34.3 5.03 5.09 0.30 0.02 
Firmicutes Turicibacter 5.08 5.79 6.44 0.74 5.08 -0.37 0.74 0.46 0.01 
1 
Treatment: 1 = litter received colostrum and post-colostrum milk feeding from their own dam; 2 = litter exchanged at birth to receive 
colostrum from a foster dam and then returned to their own dam for post-colostral milk feeding for the subsequent days; and 3 = litter 
exchanged at birth to receive colostrum and post-colostrum milk feeding from a foster dam, they remained with the foster dam for the 
subsequent days. 
2
 Greatest standard error of mean (SEM). 
3
 Trt = treatment; Day = 0 and 21. 
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1 
Treatment: 1 = litter received colostrum and post-colostrum milk feeding from their own dam; 2 = litter exchanged at birth to receive 
colostrum from a foster dam and then returned to their own dam for post-colostral milk feeding for the subsequent days; and 3 = litter 
exchanged at birth to receive colostrum and post-colostrum milk feeding from a foster dam, they remained with the foster dam for the 
subsequent days. 
2
 Greatest standard error of mean (SEM). 
3
 Trt = treatment; Day = 0 and 21. 
Table 2.4. Bacteria genera present in nasal samples of treatment 1, 2, and 3 at day 0 and 21 
Phylum Genera 
Treatment 
SEM 
Day 
SEM 
P 
1 2 3 0 21 Trt Day 
Firmicutes Aerococcus 1.15 0.98 0.85 0.15 1.15 0.17 0.15 0.43 0.02 
Synergistetes Aminiphilus 0.28 0.41 0.38 0.07 0.03 0.01 0.08 0.44 0.04 
Firmicutes Anaerotruncus 0.41 0.45 0.37 0.05 0.41 0.00 0.05 0.50 0.01 
Firmicutes Butyricicoccus 0.24 0.25 0.25 0.01 0.24 -0.01 0.01 0.50 0.01 
Firmicutes Clostridium 25.1 25.2 27.0 2.23 25.05 0.66 2.23 0.76 0.01 
Firmicutes Coprococcus 2.76 3.26 3.91 0.73 2.76 -0.42 0.73 0.54 0.04 
Proteobacteria Escherichia/Shigella 1.08 0.74 1.03 0.21 1.08 0.13 0.21 0.50 0.04 
Firmicutes Ethanoligenens 0.03 0.03 0.03 0.00 0.03 0.00 0.00 0.50 0.01 
Firmicutes Eubacterium 0.34 0.28 0.35 0.05 0.34 0.03 0.05 0.62 0.02 
Firmicutes Facklamia 0.28 0.06 0.39 0.22 0.28 1.84 0.22 0.55 0.01 
Firmicutes Flavonifractor 0.39 0.37 0.48 0.06 0.39 -0.02 0.06 0.50 0.02 
Firmicutes Lactobacillus 23.8 25.3 25.7 1.07 23.8 -0.8 1.07 0.48 0.01 
Firmicutes Megasphaera 1.10 1.48 1.10 0.25 1.10 -0.12 0.25 0.50 0.04 
Proteobacteria Moraxella 10.94 2.14 9.66 9.07 10.9 78.0 9.07 0.73 0.02 
Firmicutes Oscillibacter 0.77 0.99 0.92 0.11 0.77 -0.04 0.11 0.40 0.01 
Firmicutes Psychrobacter 1.20 1.23 1.19 0.03 1.20 -0.002 0.03 0.63 0.01 
Firmicutes Saccharofermentans 0.57 0.71 0.74 0.11 0.57 -0.09 0.11 0.50 0.03 
Firmicutes Syntrophaceticus 0.65 0.78 0.86 0.14 0.65 -0.06 0.14 0.58 0.03 
Firmicutes Turicibacter 3.33 3.18 2.44 0.51 3.33 0.52 0.51 0.46 0.03 
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Table 2.5 Association between bacteria genera present in colostrum, vaginal, and fecal samples 
of the sow and bacteria genera present in the gastrointestinal (GI) tract, fecal, and nasal samples 
of the young piglet 
 
Piglet  
Sow GI Tract Fecal Nasal  
Colostrum 0.93806 0.71836 0.49668 r 
 
<0.0001 <0.0001 <0.0001 P 
 0.88 0.51 0.24 R
2
 
    
 
Vaginal 0.99982 0.64664 0.42366 r 
 
<0.0001 <0.0001 <0.0001 P 
 
0.99 0.41 0.17 R
2
 
     
Fecal 0.95626 0.56564 0.34129 r 
 
<0.0001 <0.0001 <0.0001 P 
 0.91 0.31 0.11 R
2
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Figure 2.1. Microbial diversity estimates by gastrointestinal site and treatment. 
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Figure 2.2. Microbial diversity estimates in fecal and nasal samples at day 0 and 21. 
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Figure 2.3. Bacterial phyla present in the gastrointestinal tract of the young pig by treatment. 
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Figure 2.4. Bacterial phyla present in fecal samples at day 0 and 21 of the young pig by 
treatment. 
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Figure 2.5. Bacterial phyla present in nasal samples at day 0 and 21 of the young pig by 
treatment. 
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Figure 2.6. Bacterial genera present in colostral, fecal, and vaginal of the sow. 
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Figure 2.7. Bacterial genera present in the gastrointestinal tract of the young pig by treatment. 
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Figure 2.8. Discriminant analysis of bacterial genera present in the gastrointestinal tract of the 
young pig. 
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Figure 2.9. Bacterial genera present in fecal samples of the young pig by day and treatment 
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Figure 2.10. Bacterial genera present in nasal samples of the young pig by day and treatment 
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CHAPTER 3 
EXPRESSION OF TOLL-LIKE RECEPTORS AND INFLAMMATORY CYTOKINES 
IN GUT-ASSOCIATED LYMPHOID TISSUES IN NEONATAL PIGS. 
 
INTRODUCTION 
Gastrointestinal disease (GI) is the leading cause of morbidity and economic loss in the 
swine industry (Phillips et al., 2014). Lactation remains a crucial phase in the swine industry for 
piglet survival, for this reason, several management strategies such as colostrum or cross-
fostering  have been implemented to ensure piglet survival and growth (Muns et al., 2013). Soon 
after birth the pig mucosal barrier plays an important role in the pig’s health and protection, and 
most of this protection is conferred by the mother immediately after birth through the 
administration of colostrum (Levast et al., 2014). Initially, piglets are born immunocompetent; an 
impermeable placenta prevents the circulatory transfer of immunoglobulins from pregnant sows 
to piglet. Therefore, newborn pigs must obtain immune protection through colostrum and post 
colostral milk; immunoglobulins from the mother are transferred in milk until weaning.  
Secretory IgA (sIgA) which is responsible of protecting the intestine of the developing pig 
(Evans et al., 1980) is transferred through colostrum and milk. For this reason, the newborn pig 
must consume colostrum during the first 3 days of life to receive a proper initial immune 
protection (Salmon et al., 2009; Levast et al., 2014). The recruitment of sIgA secreting plasma 
cells and maturation of gut associated lymphoid tissues (GALT) is initiated soon after birth and 
reaches maturation until 5 weeks of age (Levast et al., 2014), both plasma cells and GALT are 
stimulated by the initial microbiota. Studies have demonstrated the sole presence of bacteria 
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accounts for more than 70% of the sIgA secreted in the intestine (Macpherson and Uhr, 2004). 
Starting at birth newborns pigs are exposed to microbes in the environment and in the milk 
(Salmon et al., 2009). Several studies have demonstrated a relationship between antigenic 
stimulation within the intestine by these microbes and antibody production (Evans et al., 1980). 
Thereby, a homeostatic relationship can be described between the immune system and the 
microbiota residing in the intestine in which equilibrium is established through positive and 
negative feedback (Hooper and Macpherson, 2010). Microbial–associated molecular patterns 
(MAMPs) are conserved and necessary structures for pathogens, these structures elicit an 
immune response when recognized by epithelial cells through pattern recognition receptors 
(PRR) (Newman et al., 2013). The host activates several signaling cascades that lead to the 
production of chemokines and antimicrobial peptides (AMPSs), crucial elements in the 
protection against gastrointestinal infections (Cerf-Bensussan and Gaboriau-Routhiau, 2010; 
Cederlund et al., 2013). The toll-like receptors (TLR) are a type of PRR expressed on epithelial 
and immune cells that recognize specific bacterial structures such as lipopolysaccharides and 
promote signaling and inflammation (Balachandran et al., 2015). Together TLR and other 
binding proteins result in a translocation of transcription factor termed nuclear factor kappa-
light-chain-enhancer of activated β cells (NF-KB) which in result activates proinflammatory 
cytokines. Therefore, the establishment of this initial microbiota helps stimulate the immune 
system development in the newborn pig (Suzuki and Fagarasan, 2008). As part of a study 
assessing microbial populations in newborn pigs, this study sought to establish a baseline for 
mucosal immune gene expression in young pigs reared in a cross-fostering model given high 
quality colostrum from birth dam or foster dam upon birth. 
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MATERIALS AND METHODS 
Animal Management and Experimental Design 
Experimental procedures were approved by the University of Illinois Institutional Animal 
Care and Use Committee. Twenty-four piglets from 2 litter (12 pigs per litter), vaginally 
delivered from multiparous dams (White × Large) of the same parity on the same day, were 
enrolled in the study. Piglets were snatch farrowed at birth and placed in warm boxes under a 
heating lamp in the farrowing pen next to the sow. Daily physical examination including 
performance, appetite, and fecal score, were performed individually. Piglets were individually 
identified (ear tag) and stratified according gender, body weight, and good post-parturient health. 
Piglets were then randomly assigned to 1 of 3 treatment groups according to the source of 
colostrum and post-colostral milk feeding for 21 days, as follow: treatment 1 (n = 8), received 
colostrum and milk from their own dam; treatment 2 (n = 8), were litter exchanged at birth to 
receive colostrum from a foster dam for 24 – 36 hours and then returned to their own dam for 
post-colostral milk feeding the subsequent days; treatment 3 (n = 8), were litter exchanged at 
birth to receive colostrum and post-colostral milk from a foster dam, and they remained with the 
foster dam for the subsequent days. Each piglet was allowed to suckle colostrum for equivalent 
times. The piglets were observed to exhibit vigorous teat sucking and subsequent satiation. No 
antibiotics were administered to the sows; E. coli/Clostridium bacteria vaccine was administered 
pre-farrowing. At birth, piglets received iron, male piglets were not castrated. None of the piglets 
were administered antibiotics during the experimental period. All piglets were weight directly 
after birth and before being euthanized. 
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Sample Collection 
A group of 13 piglets were humanely euthanized at day 21 (a common weaning time in 
the pig industry). After opening the visceral cavity, esophagus and rectum were clamped to avoid 
spilling of gastrointestinal digesta and thus contamination of other intestinal parts. Immediately 
after removing the gastrointestinal tract from the visceral cavity, standardized locations of the 
stomach, jejunum, ileum, and colon were exposed with sterile instruments. A 2 cm
2
 portion of 
the tissue was excised and placed in a tube with 5 mL RNA LATER® (Sigma-Aldrich, Saint 
Louis, MO) for quantitative real-time PCR (qPCR) analysis and stored at -80 upon arrival. The 
remainder of the animals (n = 11) were penned together at weaning (day 21) and grown to 
market weight in pens that only contain study pigs. They were reared in a room with their 
farrowing cohort and cared for by farm staff according to standard practices.  
 
RNA Isolation, Quality Assessment, and cDNA Synthesis  
Intestinal samples from jejunum, jejunum peyer’s patches, jejunum lymph node, ileum, 
ileum lymph node, ileum peyer’s patches, colon, and colon lymph node were independently 
processed. Two cm
2
 of each intestinal tissue were cut and stored in RNA LATER® according to 
manufacturer’s instructions. Extraction of RNA was achieved using Qiagen RNeasy Mini Kit 
(Qiagen, Valencia, CA) and following manufacturer’s directions for animal tissue. Thirty mg of 
intestinal mucosa were isolated by cutting with a sterile surgical scalpel blade and homogenizing 
in 600 µL of RLT buffer (Qiagen, Valencia, CA) using the Bullet BlenderTM (Next Advance) in 
which dry ice could be incorporated during the homogenization of samples. Less than 30 mg of 
tissue was recommended for tougher tissues such as lymph nodes. Samples were stored at −80 
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°C at all times. The RNA concentration was measured with Nanodrop ND-1000 
spectrophotometer. The purity of RNA was assessed by ratio of optical density OD 260/280, 
which was above 1.9 for all samples. Following RNA isolation, a portion of the RNA was 
diluted with DNase/Rnase free water (Sigma-Aldrich, Saint Louis, MO) for cDNA synthesis 
through reversed transcriptase PCR. The cDNA was synthesized using 100 ng of RNA and 
diluted with nuclease free water. The mix was prepared by combining 80 µL of diluted RNA 
with 20 µL of qScript DNA SuperMix (Quanta Biosciences, Beverly, MA). Reaction mixtures 
were incubated in a BioRad T100 Thermal Cycler for 5 minutes at 25 °C, 30 minutes at 42 °C, 5 
minutes at 85 °C, and held at 4 °C indefinitely. The cDNA was then diluted 1:4 with 
DNase/Rnase free water. 
 
Primer Design and Evaluation 
Forward and reverse primers for TLR 2, 4, and 10, tumor necrosis factor alpha (TNFα), 
interferon gamma (IFNγ), interleukin 2 (IL2), interleukin 4 (IL4), and the house keeping genes 
beta 2 microglobulin (β2M), Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and beta-
actin (ACTB) were obtained from Integrated DNA Technologies (IDT, Coralville, IA). Table 3.1 
shows the list of all primers used for qPCR analysis in this study. Then, primers were aligned 
against NCBI database through BLASTN (blast.ncbi.nlm.nih.gov) to determine the compatibility 
of primers with already annotated sequence of the corresponding gene in the database. Primers 
were reconstituted with nuclease free water in the amount of µL equal to 10 times the number of 
nMoles. Prior to qPCR, primers were verified through a 25 µL PCR reaction, which followed the 
same procedures for qPCR. Four µL of PCR product was run in a 2% agarose gel stained with 
SYBR Safe Gel Stain (Invitrogen, Carlsbad, CA), and the remaining was cleaned with QIAquick 
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PCR Purification Kit and sequenced at the Core DNA sequencing facility at the University of 
Illinois. The sequencing product was confirmed through BLASTN at the National Center for 
Biotechnology Information (NCBI) database. Only primers that presented a single band of the 
expected size and the right amplification product were used for qPCR. 
 
Quantitative Real-Time PCR 
Amplification and qPCR measurements were performed using the Applied Biosystems 
7500
®
 Real-Time PCR with version 2.0.6 software. Experiments were performed in 96-well 
plates. Within in each well, 10 µL of diluted cDNA combined with 12.5 µL of Perfecta SYBR 
Green (Thermo Fisher Scientific Waltham, MA), 0.1 µL of forward primer, 0.1 µL of reverse 
primer, and 2.3 µL of nuclease free water. Five-point standard curves plus the non-template 
control (NTC) were run for each sample to test the relative expression level. Quantitative real-
time PCR was conducted, as follow: 2 minutes at 50 °C, 5 minutes at 95 °C, 40 cycles of 15 
seconds at 95 °C and 1 minute at 60 °C, and 2 cycles of 15 seconds at of 95 °C and 65 °C for 1 
minute for the melt curve. All the analyses, including the threshold cycle (Ct) were automatically 
established using the default settings. Data was analyzed and transformed using the standard 
curve and the Applied Biosystems 7500 software. Data were then normalized with the geometric 
mean of the internal control Genes (ICG). 
 
Quantitative Real-Time PCR Performance 
Efficiency of qPCR amplification for each gene was calculated using the standard curve 
method [Efficiency = 10(–1/slope)]. Relative mRNA abundance among measured genes was 
calculated, using the inverse of qPCR efficiency raised to ΔCt (gene abundance = 1/EΔCt, where 
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ΔCt = Ct of tested gene – geometric mean Ct of 3 internal control genes). Overall mRNA 
abundance for each gene was calculated using the median ΔCt, and overall percentage of relative 
mRNA abundance was computed from the equation: 100 × mRNA abundance of each individual 
gene / sum of mRNA abundance of all the genes investigated (Table 3.2). 
 
Statistical Analysis 
Statistical analysis of collected data was performed using SAS (v9.4 Institute Inc., Cary, 
NC). Linear mixed models using the MIXED procedure (Littell et al., 1998) were constructed to 
analyze relative mRNA expression of TLR and inflammatory cytokines. For every TLR and 
inflammatory cytokine analyzed the model contained the fixed effects of treatment, tissue, and 
their interaction. Pig was considered as random effect. Least squares means were calculated and 
are presented with the respective standard error (SEM). Degrees of freedom were estimated by 
using the Kenward-Roger method (Littell et al., 1998) in the model statement. Residual 
distribution for each variable was assessed for normality and homoscedasticity. Residual 
distribution for TLRs and inflammatory cytokines were found lacking of normality and 
homoscedasticity. Therefore, data were transformed using the Box-Cox procedure of SAS. The 
log was found to be best transformation for TLRs and inflammatory cytokines data. Statistical 
significance was declared at P ≤ 0.05 and trends toward significance effects were noted when 
0.05 < P ≤ 0.10. 
 
RESULTS 
Relative mRNA Expression of TLR in the GI Tract of Young Pigs  
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Pigs remained clinically healthy throughout the study and did not reveal diarrhea. Tissues 
from intestinal mucosa in jejunum, jejunum lymph node, jejunum peyer‘s patches, ileum, ileum 
lymph node, ileum peyer’s patches, colon, and colon peyer’s patches were used to assess relative 
mRNA expression of TLR2, TLR4, and TLR10. The mRNA expression of the aforementioned 
TLR was detectable in all tested tissues. However, treatment did not have effect (P > 0.05) on 
their relative mRNA expression (Table 3.3). Relative mRNA expression of TLR2, TLR4, and 
TLR10 changed (P < 0.01) among biogeographical locations in the GI tract of young pigs (Table 
3.4). Higher expression (P < 0.01) of TLR2 was observed in jejunum lymph nodes, ileum, ileum 
lymph nodes, ileum peyer’s patches, colon, and colon lymph nodes tissues, whereas lower 
expression occurred in jejunum and jejunum peyer ‘s patches (Figure 3.1). Similarly, TLR4 
expression was higher (P < 0.01) in jejunum lymph nodes, ileum, ileum lymph nodes, ileum 
peyer’s patches, and colon tissues, whereas lower expression was observed in jejunum, jejunum 
peyer ‘s patches, and colon lymph nodes (Figure 3.2). Expression of TLR10 was higher (P < 
0.01) in ileum, ileum lymph nodes, and ileum peyer’s patches tissues, whereas lower expression 
occurred in jejunum, jejunum peyer‘s patches, colon, and colon lymph nodes (Figure 3.3). 
Constantly higher expression of TLR’s were observed in ileum and colon.  
 
Relative mRNA Expression of Immunoregulatory Cytokines in the GI Tract of Young Pigs  
The mRNA expression of anti-inflammatory cytokines TNFα, IFNγ, IL4, and IL10 was 
detectable in all tested tissues. However, treatment did not have effect (P > 0.05) on their relative 
mRNA expression (Table 3.3). The mRNA expression of TNFα, IFNγ, IL4, and IL10 changed (P 
<0.05) among biogeographical locations in the GI tract of young pigs (Table 3.4). Higher (P < 
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0.01) mRNA expression of TNFα was observed in jejunum lymph nodes, jejunum peyer’s 
patches, ileum, ileum lymph nodes, ileum peyer’s patches, colon, and colon lymph nodes tissues, 
whereas lower expression occurred in jejunum (Figure 3.4). Likewise, IFNγ and IL4 expression 
were higher (P < 0.01) in most sections of the GI tract, except in jejunum, of young pigs (Figure 
3.5 and Figure 3.6, respectively). Higher (P = 0.02) expression of IL10 was observed in jejunum, 
jejunum lymph nodes, ileum, ileum lymph nodes, ileum peyer’s patches, and colon lymph nodes 
tissues, whereas lower expression occurred in jejunum peyer’s patches and colon (Figure 3.7). 
Overall, our data suggested that expression of TLR (2, 4, and 10) and cytokines (TNFα, 
IFNγ, IL4, and IL10) were more consistent in ileum peyer’s patches and lymph nodes tissues. 
Thus, revealing novel information about the distribution and expression patterns of these in the 
GI tract of the piglet. 
 
DISCUSSION 
Gastrointestinal diseases bring great economic loss to the swine industry. The intestinal 
epithelium (IEC), peyer’s patches, and gut associated lymphoid tissues all work together to 
withstand infections. The innate immune response included the toll-like receptors play a crucial 
role in the detection of microbes and promotion of immunoregulatory cytokines (Uddin et al., 
2013).  Recognition of microbial products by toll-like receptors leads to an inflammatory 
response (Fukata and Abreu, 2008), there are more than ten TLR molecules that recognize 
microbial products. These TLR’s are divided according to their localization on the cell and the 
ligand they recognize (Uenishi and Shinkai, 2009). TLR 2 and TLR 4 are expressed on the cell 
surface; TLR 4 recognizes lipopolysaccharides (LPS) and TLR 2 recognizes peptidoglycans and 
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lipoteichoic acid found in gram positive bacteria. TLR10 ligand has not yet been identified 
although research suggests it is associated with the signaling protein myeloid differentiation 
primary response gene 88 (MYD88).  For certain TLR’s MY88 molecules promote inflammatory 
cytokines such as TNFα. For TLR 4 signaling is dependent on a TIR (toll-IL-1 receptor) domain 
that induces transcription of type I IFNs. TLRs are necessary to promote a balanced immune 
response. As part of a larger study assessing microbial populations in newborn pigs, and 
supporting the idea that the GI microbiota is involved in the development and regulation of the 
immune system, this study sought to establish a baseline for mucosal immune gene expression in 
young pigs reared in a cross-fostering model. Quantitative real-time PCR is one of the most 
widely used techniques for reliable quantification of mRNA (Derveaux et al., 2010). In the 
present study, qPCR was used to assess the expression of important pattern-recognition receptors 
and immunoregulatory cytokines in the gut of newborn pigs. Three housekeeping genes were 
utilized and qPCR efficiency was measured by standard curves with trustworthy correlation 
coefficient. Therefore, we are confident that the results obtained are reliable. In general, our 
results revealed that TLR were expressed higher in ileum and ileum associated lymph tissues of 
young pigs (21 days). Higher mRNA expression was seen in ileum peyer’s patches and lymph 
nodes. According to Kelly and Mulder (2012), peyer’s patches are a crucial region where the 
immune system is stimulated and regulated, comprised of structured lymphoid tissues that 
directly sample antigens from the intestine. Additionally, unlike the colon, ileum has a much 
thinner mucus layer, thus enabling microbe-epithelial interaction. The overall expression of TLR 
was low, in a study performed by  Kitazawa et al. (2008)  expression levels of TLR family are 
regulated by microbiota established after birth, these microbiota is responsible for promoting a 
balanced immune response. In a similar way, Hrncir et al. (2008) agreed that the interaction of 
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microbial molecular patterns with pattern recognition receptors (TLRs) in dendritic cells located 
in peyer’s patches results in a relocation to the mesenteric lymph nodes and later presentation to 
T cells via a MHC class II-antigen complex, which activates and differentiates T cells and 
promotes production of cytokines. In our study, animals were 21 days old and therefore no 
excessive inflammation was promoted since microbial colonization is commencing. Moreover, 
pigs were healthy and no intestinal disease was revealed, thereby, no tissue damage occurred. 
Akira and Takeda (2004) highlighted the association between tissue damage and TLR4 
expression. It is possible, therefore that microbial establishment and maturation in the gut is 
crucial for the regulation of the immune system. Additionally, according to Cheng et al. (2015) 
TLRs are highly expressed 6 – 12 weeks after birth. Likewise, Uddin et al. (2011) asserted that 
TLR2 mRNA expression was augmented in full-grown pigs. Tohno et al. (2006) found increased 
expression of TLR2 and TLR9 in adult GALT. Thus, it can be suggested that the overall low 
expression of TLR obtained in our study can be attributed to the age of the young pig and a low 
promotion of expression by the microflora at that early age. Kogut and Arsenault (2016) 
performed a study in broiler chickens and found regional differences in the microbiome, 
associated with regional differences in immune gene expression. A negative correlation between 
pro-inflammatory cytokine genes and the presence of Firmicutes was established as well as a 
positive correlation between pro-inflammatory cytokine genes and the presence of 
Proteobacteria. In our study colon had a lower abundance of Proteobacteria and a lower 
expression of cytokines and TLR’s especially in that of treatment 3. Colon mRNA expression 
was low compared to ileum or jejunum.  Higher expression of Proteobacteria was seen on day 
21 compared to day 0, which is in accord to previous authors that promotion of expression by the 
microflora increases with age. Although we did not measure immune gene expression over time, 
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this is definitely something to look into. Although we did not associate the microbiota found with 
immune gene expression, we did find regional differences in the microbiome and regional 
differences in immune gene expression. 
 Our observation that the abundance of TLR mRNA expression is different between 
tissues is consistent with previous studies (Sang et al., 2008; Uddin et al., 2011; McDermott and 
Huffnagle, 2014). A possible explanation is that each tissue has different function. Nutrient 
absorption occurs in the small intestine and water absorption in the large intestine, this particular 
functionality is mainly attributed to the microbiota composition which may possibly be the 
underlying element that regulates the expression of TLR and overall immunological homeostasis. 
For this reason, it is important to measure gene expression at different time points in each tissue 
and microbiota assessment as well, to determine the variation of mucosal immunity and 
microbiota shift of the pigs as it ages. 
 
CONCLUSION 
The present study confirmed the mRNA expression of TLRs and inflammatory cytokines 
in gastrointestinal tissues and gut-associated lymphoid tissues. Differential expression patterns of 
TLRs and anti-inflammatory cytokines in tissues revealed that TLRs recognition and immune 
response is not only bound to immune cells, but also to non-immune cells. TLRs may play a role 
in immune modulation and higher exposure to microbes could potentially create a definitive 
balance between pathogen and commensal bacteria in the gut. Although mRNA expression 
confirms the presence of TLRs and inflammatory cytokines, the functional importance of these 
needs to be further investigated. For future studies establishing the relationship between 
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microbiota and specific genera with immune gene expression are necessary to elucidate hey 
microbes crucial in immune modulation. In addition, the immune mechanisms at a cellular level 
are needed to understand TLR recognition and inflammatory response at different histological 
layers.  
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Table 3.1. Primers used for reverse transcriptase-PCR of swine cytokines 
Gene name Forward (5'→3') Reverse (5'→3') 
GenBank 
accession 
swTNFα 
GCCCTTCCACCAACGTTTTC CCCAGGTTGCATCCAGGAAT NM_214022.1 
swine porcine tumor necrosis alpha 
swIFNγ 
GATCCAGCGCAAAGCCATCA TCTGGCCTTGGAACATAGTCTG NM_213948.1 
swine interferon gamma 
swIL4 
CTCCCAACTGATCCCAACCC TGCACGAGTTCTTTCTCGCT NM_214123.1 
swine interleukin 4 
swIL10 
GTGCTCTCCCTGCCAAAGAT AATGGGGAGGCCTCACTGAA NC_010451.3 
swine interleukin 10 
swTLR2 
GGAATGTACCTTTGGCCCGA ACGGTGTGCTGCAAGGTAAT NC_010450.3 
swine toll-like receptor 2 
swTLR4 GCTTTTACCACTATCCAGAGC
A 
ATTGGCATCCCGCTCAGTTT NC_010443.4 
swine toll-like receptor 4 
swTLR10 
CCTCGGAGATAGGCATGCTG TTGGGTTGGGACCCTATTCC NC_010450.3 
swine toll-like receptor 10 
swGAPDH 
CTGCTCGGGAAAACCACACT TGTGTTGGGGGATCGAGTTG NC_010447.4 swine Glyceraldehyde 3-phosphate 
dehydrogenase 
swβ-2M 
CAACCACTTTTCACACCGCT TGTGATGCCGGTTAGTGGTC NM_213978.1 
swine beta-2 microglobulin 
swβ-actin 
AGGGTCAGGATGCCTCTCTT GGCTTCCTTTGTCCCCAATC NC_010445.3 
swine beta-actin 
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Table 3.2.  Median cycle threshold (Ct) of qPCR, slope, coefficient of determination of the standard curve (R2), and efficiency of 
amplification 
Gene name Median Ct
1
 Slope
2
 (R
2
)
4
 Efficiency
3
 
Relative mRNA 
Abundance
4
 
TLR2 22.62063789 -3.48765 0.99655 1.935200729 44.82404517 
TLR4 25.06811333 -3.68455 0.99545 1.888114812 10.62742834 
TLR10 26.88232994 -3.63135 0.99115 1.895296586 2.688739481 
TNFα 25.34217644 -3.6763 0.98832 1.870736507 8.977664625 
IFNγ 27.65718079 -3.6114 0.99655 1.891911969 2.853841436 
IL4 23.1246 -34917 0.99756 0.933721936 22.20647484 
IL10 26.43345 -395595 0.985632 1.893267785 7.821806101 
1 
Ct = median cycle threshold which is defined as the number of cycles required for the fluorescent signal to cross the threshold (i.e. 
exceed background level); and the amount of target nucleic acid in the sample is inversely correlated to Ct cycles (i.e., the greater the 
amount of target nucleic acid the lower the Ct cycles will be required). 
2 
Slope of the 5-point standard curve. 
3 Efficiency of amplification [E=10(−1/slope)]. 
4 Relative mRNA abundance was calculated as percentage of (1/EΔCt) specific gene in the sum (1/EΔCt) all genes. 
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Table 3.3. Least square means and associated SEM for expression of genes related to inflammation and pattern recognition 
 
Treatment¹ 
SEM
2
 
P
3
 
Gene 1 2 3 Trt Tissue Trt × Tissue 
TLR2 1.41 1.58 0.85 0.33 0.45 <0.01 0.85 
TLR4 0.24 0.32 0.45 0.45 0.33 <0.01 0.001 
TLR10 1.63 1.42 1.20 0.49 0.65 <0.01 0.08 
TNFα 1.62 1.18 0.74 0.87 0.54 <0.01 0.19 
IFNγ 1.57 1.44 0.71 0.93 0.62 <0.01 0.23 
IL4 1.40 1.49 1.16 0.38 0.73 0.01 0.34 
IL10 2.03 1.84 1.18 0.66 0.74 0.02 0.03 
1 
Treatment: 1 = litter received colostrum and post-colostrum milk feeding from their own dam; 2 = litter exchanged at birth to receive 
colostrum from a foster dam and then returned to their own dam for post-colostral milk feeding for the subsequent days; and 3 = litter 
exchanged at birth to receive colostrum and post-colostrum milk feeding from a foster dam, they remained with the foster dam for the 
subsequent days. 
2
 Greatest SEM. 
3
 Trt = 1, 2, and 3; tissue = jejunum, jejunum lymph node, jejunum peyer's patches, ileum, ileum lymph node, ileum peyer's patches, 
colon, and colon lymph node; trt × tissue = interaction of treatment and tissue. 
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Table 3.4. Least square means and associated SEM for expression of genes related to inflammation and pattern recognition 
 
Tissue
1
 
SEM
2
 
P
3
 
Gene JEJ JLN JPP ILE ILN IPP COL CLN Trt Tissue Trt × Tissue 
TLR2 0.55
c
 1.60
abc
 0.55
ac
 1.95
ab
 1.50
a
 1.26
ab
 1.72
ab
 1.13
abc
 0.40 0.45 <0.01 0.85 
TLR4 0.57
b
 1.24
ab
 0.96
b
 1.90
ab
 1.70
a
 0.86
ab
 1.19
ab
 0.65
b
 0.37 0.33 <0.01 <0.01 
TLR10 0.40
c
 2.33
ab
 1.11
bc
 1.93
a
 2.09
a
 1.65
ab
 0.60
c
 1.24
abc
 0.49 0.65 <0.01 0.08 
TNFα 0.45b 1.12a 1.68ab 1.58a 1.54a 1.30a 0.96ab 0.81ab 0.70 0.54 <0.01 0.19 
IFNγ 0.49b 1.51a 2.36ab 0.60ab 1.75a 1.16a 1.23a 0.81a 0.83 0.62 <0.01 0.23 
IL4 0.70
b
 1.18
ab
 1.04
ab
 1.15
ab
 1.69
ab
 1.71
a
 1.86
ab
 1.46
ab
 0.46 0.73 0.01 0.34 
IL10 1.12
ab
 1.92
ab
 1.81
b
 2.59
a
 2.16
ab
 1.83
ab
 0.92
b
 1.12
ab
 0.77 0.74 0.02 0.03 
1 
JEJ = jejunum, JLN = jejunum lymph node, JPP = jejunum peyer's patches, ILE = ileum, ILN = ileum lymph node, IPP = ileum 
peyer's patches, COL = colon, and CLN = colon lymph node. 
2
 Greatest SEM. 
3
 Treatment: 1 = litter received colostrum and post-colostrum milk feeding from their own dam, 2 = litter exchanged at birth to 
receive colostrum from a foster dam and then returned to their own dam for post-colostral milk feeding for the subsequent days, 
and 3 = litter exchanged at birth to receive colostrum and post-colostrum milk feeding from a foster dam, they remained with the 
foster dam for the subsequent days; tissue = jejunum, jejunum lymph node, jejunum peyer's patches, ileum, ileum lymph node, 
ileum peyer's patches, colon, and colon lymph node; trt × tissue = interaction of treatment and tissue. 
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Figure 3.1. Relative mRNA expression of toll-like receptor 2 (TRL2) in the jejunum (JEJ), 
jejunum lymph node (JLN), jejunum peyer's patches (JPP), ileum (ILE), ileum lymph node 
(ILN), ileum peyer's patches (IPP), colon (COL), and colon lymph nodes (CLN) of young 
pigs. Treatment: P = 0.40; tissue: P < 0.01; and interaction of treatment and tissue: P = 0.85.  
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Figure 3.2. Relative mRNA expression of toll-like receptor 4 (TRL4) in the jejunum (JEJ), 
jejunum lymph node (JLN), jejunum peyer's patches (JPP), ileum (ILE), ileum lymph node 
(ILN), ileum peyer's patches (IPP), colon (COL), and colon lymph nodes (CLN) of young 
pigs. Treatment: P = 0.33; tissue: P < 0.01; and interaction of treatment and tissue: P < 0.01.  
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Figure 3.3. Relative mRNA expression of toll-like receptor 10 (TRL10) in the jejunum (JEJ), 
jejunum lymph node (JLN), jejunum peyer's patches (JPP), ileum (ILE), ileum lymph node 
(ILN), ileum peyer's patches (IPP), colon (COL), and colon lymph nodes (CLN) of young 
pigs. Treatment: P = 0.49; tissue: P < 0.01; and interaction of treatment and tissue: P = 0.08.  
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Figure 3.4. Relative mRNA expression of tumor necrosis factor alpha (TNFα) in the jejunum 
(JEJ), jejunum lymph node (JLN), jejunum peyer's patches (JPP), ileum (ILE), ileum lymph 
node (ILN), ileum peyer's patches (IPP), colon (COL), and colon lymph nodes (CLN) of 
young pigs. Treatment: P = 0.54; tissue: P < 0.01; and interaction of treatment and tissue: P = 
0.19.  
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Figure 3.5. Relative mRNA expression of interferon gamma (IFNγ) in the jejunum (JEJ), 
jejunum lymph node (JLN), jejunum peyer's patches (JPP), ileum (ILE), ileum lymph node 
(ILN), ileum peyer's patches (IPP), colon (COL), and colon lymph nodes (CLN) of young 
pigs. Treatment: P = 0.62; tissue: P < 0.01; and interaction of treatment and tissue: P = 0.23.  
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Figure 3.6. Relative mRNA expression of interleukin 4 (IL4) in the jejunum (JEJ), jejunum 
lymph node (JLN), jejunum peyer's patches (JPP), ileum (ILE), ileum lymph node (ILN), 
ileum peyer's patches (IPP), colon (COL), and colon lymph nodes (CLN) of young pigs. 
Treatment: P = 0.73; tissue: P = 0.01; and interaction of treatment and tissue: P = 0.34.  
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Figure 3.7. Relative mRNA expression of interleukin 10 (IL10) in the jejunum (JEJ), 
jejunum lymph node (JLN), jejunum peyer's patches (JPP), ileum (ILE), ileum lymph node 
(ILN), ileum peyer's patches (IPP), colon (COL), and colon lymph nodes (CLN) of young 
pigs. Treatment: P = 0.74; tissue: P = 0.02; and interaction of treatment and tissue: P = 0.03. 
 
